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INTRODUCTION
The chemical structure of the phenanthridinium
compounds is shown in Figure 1.

The biological properties

of these compounds, as well as the physicochemical effects
of one of them, ethidium bromide (3.8-diamino-5-ethyl-6phenyl phenanthridinium bromide), (usually abbreviated EB),
on nucleic acids have been the subject of intense investigation in the past two decades.
,·
Studies of the properties of phenanthridinium ··

compounds have been carried out by two distinct approaches.
Initially, the biological effects of these compounds were
studied, occasionally as a function of their chemical
structure.

In contrast, during the past ten years, research

in this subject has been increasingly oriented towards the
physicochemical properties of the complexes of EB with
nucleic acids.
1.

Biological activity of phenanthridinium compounds
Phenanthridinium compounds were first found to

possess antitrypanosomal activity in 1938 (Browning, 1938).
Later, they were also found to act as antibacterial (Seaman
and Woodbine, 1954) and antiviral agents (Dickinson et al.,
1953).
The in vivo antitrypanosomal activity of the best
studied phenanthridinium drug, ethidium bromide, is observed
1

2

Figure 1.
compounds.

General formula of the phenanthridinium

The compounds used in this study have the follo-

wing substituents:
EB: R1 = R4 = NH2 , Rz = ethyl, R3 = phenyl.
DDMB: Rl = R4 = NHz, R2 = R3 = methyl.
DEMB: Rl = R4 = NH2 , Rz = methyl, R3 =·ethyl.
MAPAC: Rl = H, ~~Rz = allyl, R3 = Q-aminophenyl, R4 = NHz.
MAPEC: Rl = H, Rz = ethyl, R3 = Q-aminophenyl, R4 = NH2.
MMPB: Rl = H, R2 = methyl, R3 = phenyl, R4 = NH .
2

1

6

5

-N

+'R2

p
3

as a decrease in the number of trypanosomes in the blood
of infected animals.

This decrease is not immediate upon

exposure to EB, but it is preceded by a lag phase of approximately 3 to 4 days (Hawking and Sen, 1960).

As early as 4

hours after contact with the drug, however, basophilic
granules, consisting mainly of nucleoprotein, are observed
in the cytoplasm of the trypanosomes (Ormerod, 195lb).
These granules do not immediately influence the development
of the organisms, which, 24 hours after exposure to the drug,
are still actively multiplying.

The cell division rate,

however, later declines and, after more prolonged contact
with EB, an increased number of multinucleate and a decreased number of dividing forms are observed (Ormerod, 195lb;
Ormerod, 1961).
Analogous morphological alterations in the kinetoplasts of trypanosomes grown in the presence of EB in vitro
have been reported (Riou, 1967a).
Similar effects are also observed when Crithidia
oncopelti are exposed to EB in vitro.

Ribonucleoprotein

granules appear in the cytoplasm but multiplication of the
organisms is not inhibited until at least one cycle of
division has been completed (Newton, 1957).

It was also

noted that transfer of the organisms to a drug-free medium,
after their multipli~ation had been inhibited by EB, did
not restore their ability to multiply.

However, if the

4

organisms' exposure to the drug was terminated before their
multiplication was completely inhibited, they continued to
grow and multiply, albeit at decreased rate.

It is interes-

ting to note that the decrease in the multiplication rate is
proportional to the organisms' exposure to the drug.
These findings, along with the.observation

that~

oncopelti maintained in a non growth-supporting medium,
exposed to EB and later transferred to a drug-free growthsupporting medium grew at a normal rate (Newton, 1957),
indicate that growth in the presence of EB is an essential
condition for the lethal action of the drug.
Morphological and physiological alterations in the
presence of EB, similar to those produced in trypanosomes,
are also observed in other systems, such as algae; swelling
of the chloroplasts and decomposition of the organelles' internal membrane systems is reported as a result of growth in
the presence of EB (Heilporn and Limbosch, 1971).

Similar-

ly, EB causes morphological alterations of the smooth endo-.
plasmic reticulum and the mitochondria in various lines of
mammalian cells.

These changes are accompanied by reduction

and eventual disappearance of several respiratory enzymes
(Nass, 1970; Naum and Pious, 1971; King et al., 1972).
On the molecular level, considerable evidence has
been accumulated suggesting that EB interferes with the metabolism of nucleic acids.

As early as 1957 it was reported

\
5
{Newton, 1957) that DNA synthesis is drastically inhibited
in

~

oncopelti grown in vitro in the presence of EB.

More

recently, EB was found to inhibit host cell mediated reactivation of UV-irradiated phage in bacteria (Shankel and
Molholt, 1973) and to block RNA synthesis in mammalian cells
{Watts, 1970).
An interesting aspect of the in vivo action of EB is
that it is generally directed selectively against non-nuclear
DNA.

This selectivity is not limited to certain

organism~

only but appears to span a wide range of the phylogenetic
spectrum.

For example, in the presence of low concentra-

tions of EB, mitochondrial DNA synthesis is selectively .inhibited in both yeast and mammalian cells and the preexisting
mitochondrial DNA of the yeast is degraded (Goldring et al,
1970; Goldring et al., 1971; Radsak et al;, 1971).

Also,

growth of trypanosomes in the presence of EB results in
selective inhibition of kinetoplastic DNA synthesis (Riou,
1967b; Delain and Riou, 1969) accompanied by the appearance
of abnormal oligomeric circular DNA molecules. in the kinetoplast (Riou and Delain, 1969).
From these and other similar observations, the hypothes~s

was developed that the primary in vivo target of EB is

the metabolism of nucleic acids.

This hypothesis was further

supported by in vitro experiments indicating that EB inhibits
the action of pancreatic deoxyribonuclease (Eron and McAuslan,
1966), ~coli and mammalian DNA polymerases (Elliott,

\
6

l963; Meyer and Simpson, 1969), ~· coli RNA polymerase
(Waring, 1965a) and RNA-dependent DNA polymerase from the
Rauscher murine leukaemia virus (Muller et al., 1971).
A number of attempts have been made to establish a
relationship between the trypanocidal activity and the molecular structure of phenanthridinium compounds.

It appears

that antitrypanosomal activity requires at least one primary
amino substituent on the phenanthridinium nucleus; a second
amino substituent further enhances trypanocidal activity
{Walls, 1945; Walls, 1947; Brownlee et al., 1950).

The

size of the quaternizing alkyl group at position 5 of the
ring seems also to be important for activity; antitrypanosomal activity increases with the length of the alkyl group
for up to 3 carbon atoms and then decreases with increasing
length of the chain (Woolfe, 1952; Woolfe, 1956).
2.

Physicochemical properties of the phenanthridinium-DNA

complex
Investigation of the physicochemical properties of
the phenanthridinium-DNA complex has been, almost exclusively, limited to the study of the properties of the EB-DNA
complex.

Ethidium bromide forms complexes with double-stran-

ded DNA and RNA (Waring, 1965b; Douthard et al., 1973) in
which the dye is strongly bound to the polynucleotide.

The

nucleic acid-bound EB cannot be removed by dialysis (Waring,
1965b) but the complex is easily dissociated if passed

\\
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through an ion-exchange column {Fuller and Waring, 1964;
Radloff et al., 1967).
The formation of a complex between EB and nucleic
acids causes a metachromatic shift in the absorption maximum
of the dye from 480 nm to approximately 518 nm (Elliott,
1963; Waring, 1965b).

On the basis of this observation,

the binding of EB to DNA can be studied and the equilibrium
parameters determined by using the Scatchard relation

"£1£ =Kn - Kr (Scatchard, 1949).

The base composition of the

nucleic acid does not seem to affect significantly the extent
of binding or the properties of the dye (Waring, 1965b;
LePecq and Paoletti, 1967).
'Scatchard plots obtained at low ionic strength from
spectrophotometric titration of EB with double-stranded
nucleic acids consist of two intersecting· straight lines
(Waring, 1965b; Douthard et al., 1973) indicating that two
distinct bindi'ng processes are taking place.

These are

usually referred to as primary and secondary binding, the
primary being the stronger of the two.
It is generally accepted that the primary binding involves intercalation, i.e. positioning of the planar dye
molecule between adjacent base pairs so that the plane of
the ring is approximately perpendicular to the axis of the
helix.

The intercalation model was first proposed by Lerman

(Lerman, 1961) to explain the binding of aminoacridines
to DNA.

In the case of EB, the forces stabilizing this
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complex are mainly hydrophobic interactions between the
DNA base-pairs and the phenanthridiniurn ring system, as
suggested by the observation that ethanol dissociates the
complex (Fuller and Waring, 1964).

Also, since the binding

of EB to DNA decreases with increasing ionic strength
(LePecq and Paoletti, 1967), hydrogen bonds, which can be
formed between ethidiurn amino groups and the negatively
charged phosphates of the DNA backbone, may also contribute
to the stabilization of the complex (Fuller and Waring,
1964).
The complex of ethidiurn bromide with double-stranded
nucleic acids exhibits physicochemical properties which are
consistent with intercalation, specificallys
1.

The intercalation model requires that the plane

of the bound drug molecules be parallel to that of the base
pairs, i.e. perpendicular to the helix axis.

Experimental

results indicating such an orientation of the bound molecule
were obtained by the use of flow dichroism and fluorescence
polarization techniques (LePecq and Paoletti, 1967).
2.

A second consequence of intercalation is the

increase in the legnth of DNA as the helix unwinds to accomodate drug molecules.

This increase has been noticed by

electron microscopy (Freifelder, 1971).

Indirect proof for

this length increase is also provided by the observation
that the intrinsic viscosity of double-stranded DNA or RNA
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solutions increases significantly in the presence of EB
(LePecq, 1965; Douthard et al., 1973).
3.

The length increase in DNA due to intercalation

is expected to result in decreased length-specific mass of
the polynucleotide because the additional length due to each
EB molecule is about the same as that of a nucleotide pair
(mean molecular weight

=

650), while the mass increment

(molecular weight of the ethidium free base
than one-half of that of a nucleotide pair.

=

315) is less

This decrease

in length-specific mass is observed as a decrease in the
sedimentation coefficient of the nucleic acid in the presence of the dye (LePecq, 1965; Douthard et al., 1973).
4.

Upon binding to double-stranded DNA, the quantum

efficiency of the EB fluorescence increases dramatically.
No increase in fluorescence is noted, however, with singlestranded DNA (LePecq and Paoletti, 1967).

Ethidium mole-

cules intercalated in double-stranded DNA are placed in an
environment of considerably lower dielectric constant
(Gersch and Jordan, 1965) than the environment of the unbound
dye, which may explain the observed fluorescence enhancement.
5.

The effect of phenanthridinium compounds on

covalently closed circular DNA constitutes perhaps the most
convincing evidence in favor of the intercalation model.

It

was found that exposure of supercoiled DNA to increasing
amounts of EB reduc'es its sedimentation velocity until it is
equal to that of nicked circular DNA.

Addition of larger
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amounts of EB results in an increase of the sedimentation
velocity of supercoiled DNA.

In contrast, the sedimentation

velocity of nicked circular DNA exhibits a monotonic decrease with increasing concentration of EB (Crawford and
Waring, 1967; Bauer and Vinograd, 1968).

These findings

were interpreted as indicative of loss and subsequent reversal of the supercoiling turns of the DNA as a result of the
local unwinding of the double helix, due to intercalation of
the drug.

Similar observations were also made with various

EB analogues, indicating that the primary amino groups at
positions 3

and 8 of the phenanthridinium ring are not man-

datory for intercalation, although derivatives lacking the
3-amino substituent exhibit a slightly lower unwinding angle
than the 3.8-diamino derivatives (Wakelin and Waring, 1974).
The angle of double-helix unwinding.upon EB intercalation was estimated by measuring the fluorescence depolao
.
rization of the EB-DNA complex to be approximately 12 per
intercalated EB molecule (Pigram et al., 1973).

This value

agrees with that originally proposed (Fuller and Waring,
1964) on the basis of model-building studies and X-ray crystallographic data, although, according to more recent evidence, the angle of unwinding may be as high as 26° per
intercalated molecule (Wang, 1974).
Secondary binding between EB and double-stranded DNA
is observed at relatively high added EB/DNA ratios and low
ionic strengths.

This binding is believed to arise mainly
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from electrostatic interactions between the DNA phosphate
residues and EB molecules attached to the outside of the
helix.

Increased ionic strength eliminates secondary bin-

ding, as evidenced from the straight-line Scatchard plots obtained under high ionic strength conditions (Waring, 1964;
Waring, 1965b).
3.

The scope of this investigation
As mentioned earlier in this Section, a number of

attempts have been made to determine the relation between the
exact chemical structure of phenanthridinium drugs and their
pharmacological properties.

The in vivo experiments perfor-

med so far have provided information as to the biological
activity of these compounds.

However, in such experiments a

large number of parameters, such as in vivo stability of the
drugs, permeability of the cell membranes to the drugs, selective binding of the drugs by various components of the blood,
etc. are involved.

Since in the in vivo

experiments these

parameters cannot be easily controlled, only empirical determinations of an overall structure-function relationship can,
at best, be obtained by in vivo studies.

Such experiments,

however, provide little information about the existence and
nature of any such relationship· on the molecular level.
As previously indicated, biological properties of
EB originate from the interaction of this compound with DNA
(see, inter alia, Newton, 1957; Delain and Riou, 1969;
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Goldring et al., 1970).

It is therefore reasonable to

assume that the specificity of action of the phenanthridinitun
drugs depends on the physical consequences of the DNA-drug
binding.

The interaction of EB with DNA influences both the

conformation and the stability of double-stranded DNA and
may, as a result, determine the functi0n of DNA as template
during replication and transcription.
In spite of accumulating information on the nature of
the interactions between EB and DNA, no successful attempts
has yet been made to account for the biochemical and pharmacological properties of the phenanthridinitun drugs on the
basis of the physicochemical properties of the DNA-phenanthridinitun complex.

This investigation was, therefore, under-

taken as an attempt to answer two interrelated but distinct
questions, namely:
A.

Does the chemical structure of the intercalated

drug molecule affect the overall conformation and stability
of the drug-DNA complex and, if so, to what extent7 and
B.

If such a change in the confonnation of the com-

plex occurs, how does this change influence the function of
the complex with respect to its role in nucleic acid metabolism.

Specifically, how is the ability of the complex to

function as a substrate or as a template for deoxyribonuclease
I and DNA polymerase I affected by the specific three-dimensional structure of the complex'?

MATERIAL AND METHODS
I.

MATERIALS

Calf thymus deoxyribonucleic acid was purchased from
Worthington Biochemical Corp., Freehold, New Jersey.
Salmon sperm deoxyribonucleic acid was obtained from
Nutritional Biochemical Corp., Cleveland, Ohio.
Deoxyribonuclease I from beef pancreas (Deoxyribonucleate oligonucleotide-hydrolase; E.C. 3.1.4.5.) was obtained from Sigma Chemical Co., Saint Louis, Missouri
(Lot number 20C-1810, prepared chromatographically; supplied
as a lyopnilized powder, 2000 Kunitz units/mg; one Kunit.z
unit will cause the absorbance at 260 nm of a DNA solution
to increase at a rate of 0.001 per ml at 25°~).
DNA polymerase I, from Micrococcus luteus (Deoxyribonucleosidetriphosphate: DNA deoxynucleotidyl transferase;
E.C. 2.7.7.7.)'was obtained from Sigma Chemical Co., Saint
Louis, Missouri (Lot number 63C-2810, prepared by column
chromatography

o~

DEAE cellulose and gel filtration media;

supplied as a lyophilized powder, ·12.5 units per mg of
protein; one unit will incorporate 10 nanomoles of total
nucleotide into an acid insoluble product in 30 min at
pH 7.0 at 37°C, using calf thymus DNA as template).
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Ethidiwn bromide (3,8-diamino-5-ethyl-6-phenylphenanthridiniwn bromide) was obtained from Calbiochem, Los
Angeles, California, Lot nwnber 100301.
Crystalline samples of the following phenanthridiniwn
compounds were kindly provided by Dr. T. I. Watkins (Boots
Pure Drug Co., Ltd., Great Britain):
3,8-diamino-5,6-dimethylphenanthridinium bromide (DDMB),
3,8-diamino-6-ethyl-5-methylphenanthridiniwn bromide (DEMB),
8-amino-6-p-aminophenyl-5-ethylphenanthridinium chloride
(MAPEC),
5-allyl-8-amino-6-p-aminophenylphenanthridiniwn chloride
(MAPAC), and
8-amino-5-methyl-6-phenylphenanthridiniwn bromide (MMPB).
These derivatives were used without further purification.
Sodiwn salts of deoxyribonucleotide triphosphates
(TIP, dGTP, dCTP and dATP) were obtained from Worthington
Biochemical Corp., Freehold, New Jersey.
Tritiated TIP was purchased from New England Nuclear,
Boston, Massachusetts (tetrasodiwn salt, specific activity
40 Ci/mmole) and from Schwartz/Mann, Orangeburg, New York
(tetralithiwn salt, specific activity 54 Ci/mmole).
Other chemicals used in these studies were of analytical reagent grade.

II. INSTRUMENTS
In these studies the following instruments were used:
Cary 15 recording spectrophotometer, Cary Instrument
Corp.
Durrum-Jasco ORD/UV-5 recording spectropolarimeter,
Durrum Instrument Co.

The instrument was modified to a maxi-

mum sensitivity of 0.002 degrees of ellipticity per cm
(SS-10 modification).
Aminco-Bowman spectrophotofluorimeter (Model 4-8202
SPF) with a ratio photometer (Model 4-8912), American Instrument Co., connected to an Omnigraphic 2000 X-Y recorder,
Houston Instrument.
Tm Analyzer and Temperature Bridge, Beckman Instrument Inc., connected to a Moseley 7035B X-Y recorder,
Hewlett Packard Corp.
Beckman LS-250 Liquid Scintillation Counter.
Lauda K-2/R Constant Temperature Circulator,
Brinkman Instruments.
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III. METHODS
1.

Preparation of stock solutions
The buffer used in these studies, unless otherwise

specified, was 0.04 tl Tris-HCl, pH 7.9.

For experiments

carried out at higher ionic strengths, NaCl was added to the
composition of this buffer so that the final salt concentration ranged between 0.025 and 5.0 M.
Calf thymus DNA was dissolved (4 mg/ml) in TrisHCl buffer after slow stirring in the cold for approximately
24 hours and then dialyzed twice against 20 volumes of the
same buffer for 48 hours.

This stock solution of DNA was

then kept in the refrigerator at 4°C.
Before every experiment, an amount of the DNA stock
solution was diluted with buffer to give a working solution.
The DNA phosphate concentration of this solution was determined spectrophotometrically using an extinction coefficient
at 260 nm of 6600 (Mahler et al., 1964).
Ethidium bromide solutions were prepared by dissolving the salt into the buffer.

The final concentration was

determined spectrophotometrically using an extinction coefficient at 480 nm of 56QO (Waring, 1965a).
The

wor~ing

solutions of the other phenanthridinium

compounds were prepared by dissolving a weighed amount of the
corresponding salt into the appropriate volume of buffer.
17
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The molar concentrations were calculated on the basis of the
amount weighed and the formula weight of the compound.

From

these preparations, the following extinction coefficients
were estimated:
MAPAC:

DDMB:

4140 at 463 nm; DEMB: 4740 at 465 nm;

4750 at 438 nm; MAPEC:

5100 at 430 nm; MMPB:

3255

at 430 nm.
All the phenanthridinium salt solutions were kept in
the dark until they were used.
2.

Preparation of the complex
Complexes of various added dye/nucleotide molar

ratios were prepared at a constant dye concentration and
varying DNA concentrations.

Typically, 2 ml of the dye solu-

tion were mixed with varying volumes of the DNA working solution and buffer was added to a final volume of 10 ml.

In

certain cases, however, as indicated, the reverse procedure
was used, i.e. the DNA concentration was kept constant and
the dye concentration was varied.
3.

Binding determination
For the determination of the amount of dye bound to

DNA, the spectrophotometric method of Peacocke and Skerett
(Peacocke and Skerett, 1956) was used.

The method is based

on the bathochromic shift in the dye absorption spectrum
upon binding to DNA.
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According to this method, if:
1.

DNA does not absorb in the wavelength region usedJ

2.

Both free and bound dye obey Beer's law over the

range of concentrations used for the binding studies;
3.

The extinction coefficient of the bound dye is

independent of the dye/DNA ratio;
4a. The bound dye is present as a single species so
that the maximum number of species present, including the
free dye, is two; or
4b. If more than one species with different spectra,
apart from the free dye, are present, the relative proportion of these does not vary with the dye/DNA ratio, then,
an isosbestic point, through which all spectra of samples
containing a constant dye concentration and varying DNA concentrations would pass, is defined.
Under these copditions, the fraction, b, of dye bound
to DNA can be calculated from the equation:
Ar - A
b =

A

f

-

Ax (Eqn. 1)
b

where Af is the absorption of the free dye, Ab is the absorption of the bound dye, an Ax is the absorption of the unknown
sample at any one wavelength.

Equation 1 is valid at all

wavelengths where the above mentioned conditions are satisfied.
However, for increased accuracy, b is calculated at the
wavelength where the difference Af - Ab is maximum.
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If the fraction, b, of DNA-bound dye is known, then
£ is defined as the molar ratio of DNA-bound dye per DNA

phosphate.
4.

Circular dichroism measurements
Circular dichroism spectra were recorded using the

Jasco spectropolarimeter.

Measurements were carried out in

cells with light paths ranging from 0.1 to 10.0 cm, so that
absorbances remained below 2.0.

This precaution was taken

because optical artifacts may be observed at absorbance
values above this limit.
Circular dichroism values are reported as molar
ellipticities (E 1 - Er)' which were calculated from the
equation:
E:

1

_ E

r

= Degrees of ellipticity (E n. 2)
33 x c x 1

·

q

where "Degrees of ellipticity" are obtained directly from·
the recorder chart, the concentration, c, is expressed in
moles per litre, and the light path of the cell, 1, is
In the calculation of the € 1 - ~r ,
the concentration of DNA-bound raLher than "total added"

expressed in centimetres.

dye was used, except as otherwise specified.
The spectropolarimeter was standardized with a
solution of d-10-camphosulphonic acid (1.0 mg/ml, supplied
by Durrum Instrument Co.).

The standard solution has an

ellipticity of +0.313 degrees at 290 nm.

The instrument
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was calibrated so that the solution causes a 15.65 cm
deflection on the 0.02 degrees/cm scale.
5,

Fluorescence measurements
Fluorescence measurements were obtained using the

Aminco-Bowman spectrophotofluorimeter.

Cells with four

optically polished windows and 1.0 cm rectangular cross
section were used.
Excitation and emission fluorescence spectra were
recorded on the Omnigraphic X-Y recorder with the X axis
calibrated to read wavelength and the Y axis to correspond
to the relative intensity reading of the Ratio Photometer.
The intensity values thus obtained were corrected
for:
1.

Fluorescence contribution of the free dyes fluo1

rescence intensity proportional to the concentration of the
free dye was substracted.
2.

Absorption of the excitation light by the sample;

since fluorescence is measured at the middle of a 1.0 cm.
cell, the correction factor is the decimal antilogarithm of
half the absorbance of the sample at the excitation wavelength.
No correction for absorption of the emission light
was made, since neither the free nor the bound dye absorb
appreciably at the emission wavelength.
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Fluorescence values were plotted as "Net molar
fluorescence", which was calculated from the Equation:
Net
A
molar
robs' x antilog z
fluo- =
rescence

-

Molar fluorescencef x Df (Eqn. J)
Db

where: robs is the observed fluorescence; A is the absorbance
of the sample at the excitation wavelength; Molar fluorescencef is the fluorescence intensity per mole of free dye;
Df is the free dye concentration; and Db is the bound dye
concentration.
6.

Elevated temperature measurements
For the study of the dependence of absorbance on

temperature, a thermostated cell holder was used in connection with the Beckman Tm Analyzer and Temperature Bridge.
With the use of these instruments the temperature of
the sample can be linearly increased at a programmed rate.
The rate used was 3°C/min unless otherwise specified.

The

temperature of the sample was monitored using a platinum
resistance probe which produces a linear change in resistance
with temperature.

The probe is immersed in a reference cell

which is being heated at the same rate as the sample-containing cell.

The probe is connected to the Temperature

Bridge, which converts the temperature-dependent resistance
of the probe to a linear 10 mV output signal.

For the recording of absorbance at a given wavelength
versus temperature, the Moseley X-Y recorder was used with
the X axis calibrated to read temperature and the Y axis to
correspond to the position of the pen of the spectrophotometer.

The X signal was obtained directly from the Tempera-

ture Bridge.

The Y signal was obtained from a potentiometer

installed on the pen-drive shaft of the spectrophotometer.
This signal was mediated by a custom-made calibration box
(Martz and Aktipis, 1971) which provides for expansion and
baseline adjustment of the scale.
Melting profiles of DNA and DNA-drug complexes were
plotted as normalized hyperchromicity versus temperature.
Normalized hyperchromicity is the hyperchromicity expressed
as percent of the final hyperchromicity value observed at
the end of the transition.

Tm, then, is defined as the tem-

perature at which a normalized hyperchromicity value of 50%
is observed.

~T

30 _ 70 is a measure of the width of the mel-

ting transition and represents the difference, in degrees,
between the temperatures at which 30% and 70%, respectively,
of hyperchromicity is observed.
7.

Deoxyribonuclease assay
The assay for DNase activity used was essentially that··

of Lindberg (Lindberg, 1964) with minor modifications.

The

method is based on the measurement of DNA hyperchromicity
at 260 nm as the polynucleotide is hydrolyzed.

r
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The assay was performed, at room temperature, as
follows:
A 3 ml aliquot of a DNA solution (0.15 mM) was added
into a tube containing 1 ml of drug solution (or buffer, in
the case of control).

The contents of the tube were mixed

and left standing for approximately 1 min.

Subsequently,

0.03 ml of the enzyme solution (0.1 mg/ml) were added, the
tube was covered with parafilm and inverted rapidly 3-4
times; the contents of the tube were then poured into a
1.0 cm cuvette and monitoring at 260 nm begun, generally
within 15 - 20 seconds after the addition of the enzyme.
The assay mixture had the following composition:
0.04 tl Tris-HCl, pH 7.9, 0.004

~

MgS04, 0.0017 tl CaCl2,

0.00011 M calf thymus DNA, and 0.75 µg/ml enzyme.
The hyperchromicity at 260 nm exhibits an initial
lag phase of approximately 20 sec., after which the absorbance increases linearly with time for at least 50 sec.
This lag phase is due to the fact that the first few phosphate bonds to be hydrolyzed are statistically situated far
apart from one another and, therefore, do not cause the
release of any hyperchromic material.
For the calculation of the initial reaction rates,
the linear part of the absorbance versus time plot, which.
follows the lag phase, was used.
Hyperchromicity at 260 nm during enzymatic degradation of the DNA-phenanthridinium complex is due to the
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production of oligonucleotides, the extinction coefficient
of which at 260 nm is higher than that of native DNA, and,
also, to the release of intercalated molecules, which have
a higher extinction coefficient at 260 nm in the free than
in the bound state.
To correct for the latter type· of hyperchromicity,
the assay was performed as described above, but this time the
absorption was monitored at a wavelength, A, at which DNA
does not absorb and where the difference between the extinction coefficients of the free and the bound dye is maximum.
For the various compounds studied, this wavelength was: EB:
460 nm; DDMB: 450 nmi MAPEC: 425 nm; MAPAC: 430 nm.

The

corrected hyperchromicity at 260 nm is:
6. A260, corr.=
· 0A A260, obs.- 6. A xA ~ 260 (Eqn. 4)

6

where

A~

6.A 260 , obs. is the observed hyperchromicity at 260 nm;

6. AA is the observed hyperchromicity at wavelength A; 6.E 260
is the difference between the extinction coefficients of the
free and bound dye at 260 nm; and 6.£

A

is the difference be-

tween the extinction coefficients of the free and bound dye
at wavelength A,
The corrected initial velocity obtained by this
method was used to construct the inhibition plots.

In these

plots, the function i/(l - i) (where i is the fractional inhibition) is plotted versus the total concentration of

26 .

inhibitor, Dt.

It has been shown (Reiner, 1959) that when

an inhibitor acts by decreasing the effective substrate
concentration, a plot of Dt versus i/(l - i) yields a curve
that passes through the origin of the axes; the initial and
final parts of this curve are straight lines with slopes of
y

1

= K3 +St
1 + St/K1

and Y =

2

K3 (1+~t),

respectively, where:

1

K1 = Dissociation constant for the binding of the
substrate to the enzyme.
K3 = Dissociation constant for the binding of the
~
inhibitor to the substrate.
St = Total substrate concentration.
When the final linear portion of the curve is extrapolated to the Dt axis, the intercept gives a value of St.
By measuring the slopes of these two linear portions
of the curve and the extrapolative

inter~ept

on the Dt axis,

one can calculate the dissociation constants for the binding
of the enzyme to the substrate and the binding of the inhibitor to the substrate.
8.

DNA polymerase assay
The method used for determining polymerase activity

was that of Bollum (Bollum, 1966).

The procedure is based

on the incorporation of radioactivity labeled deoxyribonucleotides into an acid insoluble product.
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DNA polymerase I from Micrococcus luteus was
dissolved (0.25 mg/ml) in 0.04
0.008

~

~potassium

phosphate,

MgC1 2 , pH 7.0 containing 1 mg/ml BSA and 3 mmoles/l

2-mercaptoethanol.

The mixture was subsequently divided into

1 ml portions that were kept frozen at -20°C until they were
used.
The reaction mixture contained, in a final volume of
0.3 ml, the following components at the indicated concentrations:

0.04 M potassium phosphate, pH 7.0; 0.008 M MgC1 2 ;

0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mM each of
dATP, dGTP, dCTP; 0.1 mM of tritiated TTP {approximately
15000 cpm/nmole); 0.072 mg/ml activated calf thymus DNA
(see below); 0.008 mg/ml enzyme; appropriate amounts of inhibitor (or buffer, in the case of controL).

The reaction

was usually initiated with the addition of the nucleotide
triphosphate (XTP) solution.

On occasion, the enzyme solu-

tion was used to initiate the reaction.

No significant

difference was observed between the results of the two
methods.
After incubation at 37°c for 30 min, the reaction
was stopped by immersing the test tubes containing the
I

reaction mixture in ice-water and adding 0.1 ml of ice-cold
salmon sperm DNA solution (0.3 mg/ml) containing 0.1 M
sodium pyrophosphate, followed by 0.4 ml of ice-cold 1 N
perchloric acid containing 0.1

Msodium

pyrophosphate.
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After storing at

o0 c

for approximately 15 min, the tube

contents were filtered through glass-fibre filters (Whatman
GF/C, 2.4 cm in diameter) under mild suction.

The tubes

were subsequently washed three times with a total of 15 ml
of 0.1

~

HCl, 0.01 M sodium pyrophosphate and the washings

were also filtered through the same filter.

Finally, the

filters themselves were washed twice with a total of 10 ml
of the above solution and then with 10 ml of ethanol.

The

filters were dried for approximately 10 min at 120°C and
counted in 10 ml of 0.4% PPO (2,5-diphenyloxazole) in toluene.
In every assay, one or two samples were included,
containing buffer instead of enzyme, for the determination
of background radioactivity.

~

The radioactivity of these

samples, typically less than 2% than that.of the controls,
was subtracted from the radioactivity of the rest of the
assay samples.
9.

Activation of DNA
The method used for partial digestion of DNA was

that of Harwood et al. (Harwood et al., 1970a).

The

following solutions were used:
A.
0.005

~

Calf thymus DNA (2 mg/ml) in 0.01 tl Tris-HCl,

MgC1 2 , pH 7.8.
B.

Pancreatic DNase (6.25 pg/ml) in 0.04 M Tris-

HCl, 0.004 M MgS0 4 , 0.00175 M CaC1 2 , pH 7.8.

29

B.

Pancreatic DNase (6.25 pg/ml) in 0.04 M Tris-HCl,

0.004 M MgS04, 0.00175

MCaCl2,

pH 7.8.

The enzyme was added to the DNA solution (0.012 pg
protein per mg of DNA) and the mixture was incubated for 10
min at 37°C with gentle shaking.

The period of 10 min was

chosen because it coincided with maximum template activity
of the product (Figure 2).
The reaction was stopped by immersing the tube
containing the enzyme-DNA mixture in ice-water and adding
ice-cold EDTA (0.5
0.05 M.

M,

pH 8.0) to a final concentration of

Subsequently, the DNA solution was extracted 4-5

times with equal volumes of a mixture of chloroforms
isoamyl alcohol (24: 1, v/v) and then 4-5 times with ether.
The evaporation of residual ether was accelerated by passing
a stream of nitrogen over the solution.
After the extraction, the DNA solution (approximately
10 ml) was dialyzed for 24 hours versus 4 1 of 0.01 M NaCl
solution containing 10- 4 M EDTA, pH 7.5. This solution was
finally divided into portions (2 ml each) which were kept
frozen at -20°C until they were used in the DNA polymerase
assay.
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Figure 2.

Effect of DNase digestion on templating

efficiency of calf thymus DNA.
of DNA by pancreatic DNase I.

Abscissa:
Ordinate:

time of digestion
radioactivity in-

corporated into acid insoluble product after incubation with
DNA polymerase I.
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RESULTS
1.

THE BINDING OF THE PHENANTHRIDINIUM DRUGS TO DNA
As already indicated in the Introduction, there is

evidence today suggesting that the biological action of the
phenanthridinium drugs is the result of complex formation
between these compounds and DNA.

Valuable information re-

garding the nature of forces stabilizing the complex may be
obtained by examining the effect of various substituents
of the phenanthridinium molecule, and especially the primary
amino groups at positions 3 and 8, on the ability of these
compounds to bind to DNA.

Furthermore, the binding studies

provide the necessary information for the calculation of
DNA-bound drug concentration in subsequent experiments.

For

these reasons the binding of the phenanthridinium derivatives to DNA was studied under varying conditions of ionic
strength and temperature.
The binding of the drugs to the DNA was determined
from the metachromatic shift observed in the spectrum of. the
drug as a result of titration with calf thymus DNA, as described in Section 3 (Methods).

In most instances, the ab-

sorption spectra showed good isosbestic points and provided
little, if any, evidence of drug self-aggregation.
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1.1.

Low ionic strength conditions
Binding determinations at room temperature were per-

formed in 0.04 M Tris-HCl, pH 7.9 buffer for five compounds:
EB, DDMB, MAPEC, MAPAC and MMPB.

A representative spectro-

photometric titration of EB with calf thymus DNA is shown
in Figure 3.

Scatchard plots derived from these experiments

are shown in Figures 4-8.

The binding parameters are sum-

marized in Table 1.
The Scatchard plots indicate the existence of two
distinct processes of unequal strength for the binding of the
phenanthridinium dyes to DNA.

The intrinsic association
constant calculated for EB (2 x 10 6 l/mole) is in good agree,_

ment with values obtained previously under similar conditions
(Waring, 1965b; Angerer and Moudrianakis, 1972).

Moreover,

the association constants for the primary binding for all
five compounds studied are in close agreement with each
other.

The diamino compounds, however, tend to exhibit

somewhat higher association constants.

A similar trend is

also observed for the number of binding sites per DNA ph6sphate; again, the diamino compounds appear to have a higher
number of binding sites than the monoamino derivatives,

r

indicating that the primary amino substituent at position 3
of the ring may contribute to the overall stabilization of
the complex.
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Figure 3.

Spectrophotometric titration of EB with

calf thymus DNA in 0.04 M Tris-HCl, pH 7.9 buffer.

Light

5.0 cm. (EB) = 4 x 10-S t!· (DNA) = 0 (curve A),
o.z x 10- 4 M (curve B), 0.4 x 10- 4 M (curve C), 0.8 x 10- 4 M
(curve D), 13 x 10- 4 M (curve E), 3 x 10- 4 M (curve F).
path:

400

500

.A,nm
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Figure 4.

Scatchard plot for the interaction of EB

with DNA at room temperature.
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Figure 5.

Scatchard plot for the interaction of

DDMB with DNA at room temperature.

Buffer:

0.04

HCl, pH 7.9.
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Figure 6.

Scatchard plot for the interaction of

MAPEC with DNA at room temperature.

Buffer:

Tris-HCl, pH 7.9.

6
MAP EC

4

.,
'

-

0

IC

(,)

'"

2

0.1

0.2
r

0.3

0.4

0.04 M

37

Figure 7.

Scatchard plot for the interaction of

MAPAC with DNA at room temperature.

Buffer:

0.04 M Tris-

HCl, pH 7. 9.
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Figure 8.

Scatchard plot for the interaction of

MMPB with DNA at room temperature.

Buffer:

Tris-HCl, pH 7.9.
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TABL E 1
Binding parameters for the interaction of certain
phenanthridinitun compounds with DNA

Compound

K

-as~.

(1/mole)

!!

Diamino:
2.0 x 10 6
3.8 x 10 6

0.27

0.24

MAPEC

1.3 x 10 6
0.6 x 10 6

MMPB

1.1 x 10 6

0.24

EB
DDMB

0.27

Monoamino:
MAPAC

Buffer: 0.04

MTris-HCl,

pH 7.9.

0.24

Temperature: 25°C.
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1.2.

High ionic strength conditions
In order to determine the extent of electrostatic

force contribution to the overall binding energy of the
EB-DNA complex, the binding of this compound to DNA was
studied in the presence of 5.0 M NaCl.

In addition, this

binding study provided the necessary information for the calculation of the bound dye concentration in subsequent CD
experiments that were performed under the same conditions
(Results, Section 2.3).
The Scatchard plot for the interaction of EB with
DNA in the presence of 5.0 M NaCl is shown in Figure 9.

All

points fell on a straight line, indicating that, under
these conditions, secondary binding is eliminated.

It is

also interesting to note the resulting substantial decrease
in the association constant (2.8 x 105 l/mole in 5.0 M
buffer as comP,ared with 2.0 x 10 6 l/mole in 0.04 ~buffer)
and in the number, n, of binding sites per DNA phosphate
(0.19 in 5 M buffer as compared to 0.27 in 0.04 M buffer).
These changes in the

bind~ng

characteristics of EB

are not surprising, since, at neutral pH, electrostatic
forces between the cationic dye and the negatively charged
phosphates of the helix may comprise a considerable part of
the forces stabilizing the dye-DNA complex (Gilbert and
Claverie, 1968).

Similar decreases in the association con-

stant in the presence of increased sodium ion concentrations
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Figure 9.

Scatchard plot for the interaction of EB

with DNA at room temperature.

Buffer:

0.04

5 M NaCl, pH 7.9.

6

EB

\
\
\

\
\
2

0.2

r

0.3

o.4

~

Tris-HCl,
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have also been reported previously (LePecq and Paoletti,
1967).
1.3.

Binding in the presence of magnesium
The binding of four phenanthridinium compounds (EB,

DEMB, MAPAC and MAPEC) was also studied in the presence of
magnesium ions, both at room temperature and at 37°C.

These

experiments provided binding constant values which are needed
for the estimation of the DNA-bound drug in conditions under
which the subsequent enzymic studies were performed (Results,
Sections 5 and 6).
The change in the absorption spectrum of EB upon
addition of increasing amounts of calf thymus DNA is shown
in Figures 10 and 11.

The buffer used in these experiments

was 0.04 M potassium phosphate, 0.008 M MgC1 2 , pH 7.0.
Similar absorption spectra were also recorded for the other
three phenanthridinium compounds.

The Scatchard plots for

these experiments are shown in Figures 12-15 and the binding
parameters are summarized in Table 2.
Examination of the Scatchard plots shows that all the
experimental points fall on a straight line, indicating that,
under these conditions, secondary binding is eliminated.
This is an expected finding in view of a previous report
(Waring, 1965b) that no secondary binding is observed in the
interaction of EB with DNA in the presence of 0.004 M MgClz·
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Figure 10.

Spectrophotometric titration of EB with

calf thymus DNA in 0.04 M potassium phosphate, 0.008 M
MgC1 2 , pH 7.0.

Light path: 10.0 cm.

Temperature: 25°c.
(EB) = 2 x io- 5 M· (DNA) = O (curve A), 0.5 x io- 4 M
(curve B), 0.7 x io- 4 M (curve C), 1.1 x io- 4 M (curve D),
2.3 x io- 4 M (curve E), 9.2 x io- 4 M(curve F).
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Figure 11.

Spectrophotometric titration of EB with

calf thymus DNA in 0.04
MgC1 2 , pH 7.0.

Mpotassium

Light path:

phosphate, 0.008 M

10.0 cm.

Temperature: 37°C.
(EB) = 2 x 10- 5 M. (DNA) = 0 (curve A), 0.7 x 10- 4 (curve
B), 1.2 x 10- 4 M (curve C), 1.7 x 10- 4 M (curve D),
15 x 10- 4 M (curve E).
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Figure 12.

Scatchard plot for the interaction of

EB with DNA at 25°C (0) and at 37°c (t).

Buffer:

potassium phosphate, 0.008 M MgC1 , pH 7.0.
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Figure 13.

Scatchard plot for the interaction of

DEMB with DNA at 25°C (0) and at 37°C (I).

Buffer: 0.04 M

potassium phosphate, 0.008 M MgC1 , pH 7.0.
2

5
DEMB
4

ot
I

-

0

)(

~

0

3

...

-..........

2

..............

.........

..........

0.05

0.10

0.15

r

0.20

0.25

47
Figure 14.

Scatchard plot for the interaction of

MAPEC with DNA at 25°c (0) and at 37°c (e).

Buffer: 0.04 M

potassium phosphate, 0.008 M MgC1 2 , pH 7.0.
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Figure 15.

Scatchard plot for the interaction of

MAPAC with DNA at 25°c (0) and at 37°c (t).
potassium phosphate, 0.008

~

Buffer: 0.04 M

MgC1 , pH 7.0.
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TA BL E

2

Binding parameters for the interaction of certain
phenanthridinium comi:x:>unds with DNA
37°c

25°C
Compound

(1/mole)
K
-ass.

K
(1/mole)
-ass.

Diamino:
1.6 x 105

0.20

0.20

1.0 x 10 5

0.20

0.17

1.1 x 105
1.2 x 105

0.17

0 .20

DDMB

2.2 x 10 5
1.9 x 10 5

DEMB

2.2 x 10 5
1.7 x 10 5
2.0 x 10 5

EB

0.23

Monoamino:
MA PAC
MAPEC

0.16

Buffer: 0.04 M potassium phosphate, 8

l.

m~

MgC1 2 , pH 7.0.

0 .16
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It is also evident that, under these conditions, as the case
was with measurements made in 0.04 M Tris buffer (Results,
Section 1.1), the association constants for the diamino
compounds are slightly higher than those of the monoamino
derivatives.

These differences, however, are more

ced at 25°C than at 37°C.

pronou~

The elimina~ion of the differehces

between the binding constants of the mono- and diaminoderivatives at higher temperature suggests that any advantage, in terms of binding energy, conferred upon the diamino
compounds by the primary amino group at position

c3 ,

is

almost totally eliminated by a 12-degree increase in ternperature.
It is also interesting to note that an increase

of

the temperature from 25°C to 37°C does not affect appreciably, if at all, the number, n, of binding sites per DNA
phosphate, although at the higher temperature the association
constant decreases by a factor of, approximately, two
(Table 2).

A similar observation was previously reported

in a fluorometric study of the binding of EB to DNA (LePecq
and Paoletti, 1967).
In summary, the binding data presented above are in
agreement with previous studies indicating that the interaction of phenanthridinium compounds with DNA consists of
two binding processes:

the primary binding, which is the

stronger of the two and which predominates at low added
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drug/nucleotide ratios, and the secondary binding, which
is observed at high values of these ratios.
The secondary binding is extremely sensitive to
changes in ionic strength and it is eliminated in the pres·ence of 0.008

~

MgC1 2 (Figures 12 - 15).

In fact, it has been

reported that no secondary binding could be detected in the
interaction of EB with DNA in the presence of as little as
0.004

~

MgC1 2 (Waring, 1965b).

The increased sensitivity

of this type of binding process to salt concentration indicates that secondary binding relies mainly, if not exclusively, on electrostatic forces.

This observation further

supports the idea, initially advanced by LePecq and Paoletti
(LePecq and Paoletti, 1967) that electrostatic forces are
primarily responsible for the binding of EB .to the secondary
sites of DNA.

These electrostatic forces·are exerted between

the negatively charged phosphate residues on the outside 'of
the helix and the cationic dye molecule, since, at neutral
pH, the ethidiurn molecule carries a single positive charge
due to the quaternized nitrogen at position 5 of the ring.
This mechanism of binding may very well be true also for the
other phenanthridiniurn derivatives studied.
The primary binding is also influenced by ionic
strength, although much less extensively than the secondary
binding.

This is indicated in Tables 1 and 2.

At relatively
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low salt concentration (less than

0.1~),

binding parameters

were found to decrease with increasing salt concentration.
However, at higher salt concentrations, the binding appears
independent of ionic strength (Figures 9 and 12).

Similar

findings were reported previously for the EB-DNA interaction
(LePecq et al., 1964).

It was found in that instance that

the affinity of EB for DNA becomes independent of the ionic
strength above 0.2 M for divalent ions and above approximately 1 M for monovalent ions.

These observations indicate

that the stabilizing forces of the phenanthridiniurn-DNA
complex consist mainly of two components, only one of which
is sensitive to salt concentration.
This conclusion is consistent with the model of
binding, initially proposed by Fuller and Waring (Fuller and
Waring, 1964) and subsequently supported by the work of LePecq
and Paoletti (LePecq and Paoletti, 1967).

The model postu-

lates that the DNA-EB complex is stabilized mainly by
hydrophobic forces between the DNA base pairs and the phenanthridiniurn ring system.

These forces are not expected to be

affected by increased ionic strength and should be mainly, if
not exclusively, responsible for the binding observed at
high salt concentrations.
Additional stabilization of the complex is provided
by hydrogen bonds formed between the primary amino groups at
positions 3 and 8 of the ring and the negatively charged
phosphate residues on both polynucleotide strands.

These
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interactions, in contrast wtth the hydrophobic forces mentioned in the previous paragraph, are sensitive to the salt

f

concentration of the medium.

Therefore, it appears that the

decrease in binding strength, observed with increasing salt
concentrations, is due to the elimination of these hydrogen
bonds.
2.

CIRCULAR DICHROISM STUDIES
The method of circular dichroism is especially well

suited for the study of the conformation of the phenanthridinium-DNA complexes.

CD is extremely sensitive to small

changes in the conformation of the polymer under study;
differences, therefore, in the conformation of the dye-DNA
complexes may be conveniently detected.
In addition, evidence about the conformation of a
dye-DNA complex may be obtained by relating the experimentally observed CD spectrum to that predicted by theoretical
models.
The circular dichroism of the phenanthridinium-DNA
complexes was studied in the wavelength region between 300
and 600 nm.

Neither of the components alone exhibits any

optical activity in this region.

Several bands appear,

however, in the CD spectrum when these dyes are complexed
with DNA.
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2.1.

Diamino compounds
The CD spectra of the DNA complexes of two diamino

phenanthridinium compounds (EB and DDMB) are shown in
Figures 16 and 17 (note that the ellipticity scale must be
multiplied by 0.1 for wavelengths above 350 nm).

The spectra

in each Figure are obtained from complexes containing increasing added dye/nucleotide ratios.

The striking similari-

ties between the two families of spectra should be noted.
In both cases there are three main regions of optical
activity:

one major positive band with a maximum close to

310 nm and a shoulder at, approximately, 340 nm; a negative
band with a maximum around 370 nm; and a weaker, wide
negative band with a maximum close to 500 nm.
In addition, a small negative band, centered near
295 nm, may be observed in the spectrum of the EB-DNA complex.

This band is clearly distinguishable only at the high

added dye/nucleotide samples, i.e. those containing low DNA
concentrations.

It is likely, therefore, that this band is

not observed in lower EB/nucleotide ratios merely because
it is masked by the much stronger positive band at 280 nm
of the DNA spectrum.
The significance of these bands, in respect to their
possible assymmetric source(s), will be examined in subsequent sections by studying the dependence of molar
city on the bound dye/nucleotide ratio.

ellipti~

r
'
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Figure 16.

CD spectra of the EB-DNA complex at three

(indicated) added EB/nucleotide ratios.

Ellipticity values

for wavelength above 350 nm are multiplied by a factor of

10.

20

EB

15

300

400

A,nm

500

56

Figure 17.

CD spectra of the DDMB-DNA complex at

three (indicated) added DDMB/nucleotide ratios.

Ellipticity

values for wavelengths above 350 nm are multiplied by a
factor of 10.
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2.1.1.

The circular dichroism at 500 nm
Examination of Figures 16 and 17 indicates that the

molar ellipticity of the diaminophenanthridinium-DNA complexes at 500 nm is independent of complex concentration.

This

point is more clearly illustrated in Figure 18, in which the

£1 - tr at 500 nm of the EB-DNA complex is plotted as a
function of £·
Allowing for experimental error, which, in this case,
can be substantial because of the very low optical activity
of the drug-DNA complex at this wavelength, a horizontal
line can be drawn through.all points.

The molar ellipticity

of the EB-DNA complex at 500 nm is approximately -0.4,
irrespective of the concentration of the complex.
A similar behavior is exhibited by the DDMB-DNA
complex.

The value of E1 - Er at 500 nm is, again, approximately -0.4 (Figure 19).
This independence of molar ellipticity of the complex on the concentration of DNA-bound dye is, of course,
expected as a consequence of Beer's law.
E1

Indeed, since

- Er is derived by, essentially, normalizing the observed

ellipticity to the concentration of the complex (Methods,
Section 4), it expresses the optical activity per mole of
this complex, a parameter which should be independent of
complex concentration.
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Figure 18.

Dependence of molar ellipticity of the

EB-DNA complex at the band maximum near 500 nm on r.
Buffer:

0.04 M Tris-HCl, pH 7.9 .
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Figure 19.

Dependence of molar ellipticity of the

DDMB-DNA complex at the band maximum near 500 nm on r.
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2.1.2.

The circular dichroism at 310 run
As already indicated in Figures 16 and 17, quite

different behavior is displayed by the molar
310 run.

~llipticity

at

The dependence of molar ellipticity of the EB-DNA

complex at that wavelength on £ is depicted in Figure 20.
It is evident from this Figure that, in contrast with the
behavior of the molar ellipticity at 500 run and in apparent
contradiction of Beer's law, the molar ellipticity at 310
run is not independent of complex concentration.

In fact,

E1 - Er at 310 run increases with ~ reaching an apparent
maximum of approximately 25 at an£ value between 0.30 and
0.35, a ratio which corresponds to the saturation of the
DNA-binding sites by EB.
In the case of the DDMB-DNA complex., a very similar
dependence of E 1 - Er on r is observed, as shown in Figure 21;
indeed, the molar ellipticity of the DDMB-DNA complex at
the band maximum near 310 run increases with increasing £•
The dependence appears sigmoid in shape and the molar ellipticity value reaches an apparent maximum of 20 for an £ of
approximately 0.30.
This variation of the molar ellipticity at 310 run
of the DNA-diaminophenanthridinium complexes suggests that
the mere fact that a dye molecule is bound to DNA is not a
sufficient requirement for optical activity at this wavelength.
Rather, it appears that ellipticity at the band maximum

~

61

Figure 20.

Dependence of molar ellipticity of the

EB-DNA complex at the band maximum near 310 nm on r.
Buffer:
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Tris-HCl, pH 7.9.
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Figure 21.

Dependence of molar ellipticity of the

DDMB-DNA complex at the band maximum near 310 nm on £·
Buffer:

0.04 M Tris-HCl, pH 7.9.
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near 310 nm depends on the "density" of the bound molecule
population within a given segment of the nucleic acid, indicating that this ellipticity results from interactions,
either direct of indirect, between dye molecules bound at
neighboring sites on the DNA.
2.2.

Monoamino compounds
Compared with the CD spectra of the diaminophenan-

thridinium-DNA complexes just described, the spectra of the
complexes of the monoamino substituted drugs with DNA show
considerable differences both in terms of overall shape as
well as ellipticity values.
studied:

Three monoamino compounds were

MAPEC, MAPAC and MMPB.

The CD spectra of the

complexes of these compounds with DNA at three different
added drug/nucleotide ratios are shown in Figures 22-24
(note that in this case, in contrast with the diamino dyesDNA CD spectra, the ellipticity scale above 350 nm is not
multiplied by 0.1).
Certain similarities, both qualitative and quantitative, may be noted between the spectra of the three families.
Specifically, two main areas of optical activity are distinguished in each spectrum:

one comprised of a negative

band with a maximum at, approximately, 470 nm, and an area
of positive optical activity which extends in the wavelength
region between 300 and 360 nm and which consists of at least
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Figure 22.

CD spectra of the MAPEC-DNA complex at

three (indicated) added MAPEC/nucleotide ratios.
0.04 M Tris-HCl, pH 7.9.
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Figure 23.

CD spectra of the MAPAC-DNA complex at

three (indicated) added MAPAC/nucleotide ratios.
0.04 M Tris-HCl, pH 7.9.
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Figure 24.

CD spectra of the MMPB-DNA complex at

three (indicated) added MMPB/nucleotide ratios.
0.04 M Tris-HCl, pH 7.9.
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three individual bands.

A small, negative band centered

around 390 nm may also be present.

This latter band is not

observed in the spectrum of the MMPB-DNA complex.
In quantitative terms, the spectra presented in
Figures 22 - 24 indicate that the complexes of monoamino
dyes with DNA exhibit substantially lower molar ellipticities at the short wavelength region (300 - 350 nm) as compared to the corresponding complexes of the diamino drugs.
Exactly the opposite is observed at the long (470 - 500 nm)
wavelength region, where the complexes of the monoamino
drugs have ellipticity values that are approximately five
times higher than those observed with the diamino compoupds.
These differences between the two classes of the CD
spectra examined indicate that the

conformat~on

of the

DNA-monoamino phenanthridinium complexes ts quite distinct
from that of the complexes formed from diamino derivatives.
This observation also suggests that, in general, the number
of primary amino substituents on the phenanthridinium ring
may have a significant effect on the conformation of the ·
dye-DNA complex.
Ihe conforrnation of the monoamino phenanthridiniumDNA complex was studied in more detail by examination of
the dependence of the molar ellipticity at the band maximum
near 315 nm and 470 nm on r.
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2.2.1.

The circular dichroism at 470 nm
As indicated in Figures 22 - 24, the negative band

with the 470 nm extremum displays a behavior reminiscent of
that of the 500 nm maximum of the diamino compounds, i.e.
molar ellipticity at this wavelength appears independent of
complex concentration.

The dependence·of molar CD at that

wavelength on complex concentration is shown in Figures
25 - 27.

Although the absolute magnitudes of molar ellip-

ticities of -2.4 to -3.0 are higher than those noted with
the diamino compounds, ellipticity values remain, as the
case is with diamino derivatives, constant, irrespective of
the concentration of the drug-DNA complex.

These findings

indicate that the nature of the interactions responsible
for the long wavelength dichroic band are probably not
affected significantly by the lack of the 3-amino substituent
from the intercalated molecule.
2.2.2.

The circular dichroism at the maximum near 315 nm
In contrast with the behavior of the molar CD at the

370 nm extremum, the molar CD at the short wavelength maximum is not independent of the concentration of the complex.
The dependence of the molar ellipticity of the drug-DNA
complex at the band maximum near 315 nm on the concentration of the complex is shown in Figures 28 - 30.
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Figure 25.

Dependence of molar ellipticity of the

MAPEC-DNA complex at the band maximum near 470 nm on r.
Buffer:

0.04 M Tris-HCl, pH 7.9.
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Figure 26.

Dependence of molar ellipticity of the

MAPAC-DNA complex at the band maximum near 470 nm on r.
Buffer:

0.04 M Tris-HCl, pH 7.9.
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Figure 27.

Dependence of molar ellipticity of the

MMPB-DNA complex at the band maximum near 470 nm on r.
Buffer:

0.04 M Tris-HCl, pH 7.9.
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Figure 28.

Dependence of molar ellipticity of the

MAPEC-DNA complex at the band maximum near 315 nm on £•
Buffer:

0.04 M Tris-HCl, pH 7.9.
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Figure 29.

Dependence of molar ellipticity of the

MA.PAC-DNA complex at the band maximum near 315 nm on £•
Buffer:

0.04

MTris-HCl,

pH 7.9.
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Figure 30.

Dependence of molar ellipticity of the

MMPB-DNA complex at the band maximum near 315 nm on r.
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0.04 tl Tris-HCl, pH 7.9.
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Although the molar ellipticity increases somewhat
with complex concentration, this increase is much less
pronounced than the one observed with the diamino compounds
and the final E1 - tr values are less than one-third of
those obtained with the diamino compounds for the same r
values.

In addition, this modest increase in molar ellip-

ticity is accompanied by significant changes in the shape
of the spectrum itself, as indicated by the sign-reversal
of the molar ellipticity near 315 nm.

Indeed, Figures

28 - 30 indicate that, at low bound dye/nucleotide ratios,
the ellipticity at 315 nm has negative values, although
it becomes positive at higher£ values.

This ellipticity

sign change occurs at an£ of approximately 0.10.
A similar sign change in ellipticity has been
reported for the

interactio~

of proflavine with DNA.

It

was interpreted as the result of mutual cancelling or reinforcement between three circular dichroism bands (Li and
Crothers, 1969).

In the case of monoamino phenanthridinium

compounds, at least three distinct bands may be observed
in the 300 to 350 nm region of the CD spectrum of their
complexes with DNA.

Therefore, the sign reversal for the

ellipticity at 315 nm mentioned above may reflect a mutually
cancelling relationship between some or all of these bands.

76

2.3.

Circular dichroism of the EB-DNA complex at high ionic

strength
Under the conditions the present CD studies were
performed (0.04 M Tris buffer, room temperature), two types
of binding are observed:

primary binding, involving inter-

calation of the drug molecules between,successive base
pairs, and secondary binding, representing drug molecules
bound electrostatically to the outside of the helix.

Thus

the question arises whether the observed ellipticity is the
result of only one type of binding or both.

The study of

the circular dichroism of the EB-DNA complex at high ionic
strength (5.0 M NaCl) provides information helpful in
answering this question.
In addition, high ionic strength conditions provide
a means of studying in more detail the negative CD band
observed near 295 nm in the EB-DNA spectrum.

As mentioned

earlier (Results, Section 2.1) the low ellipticity values
associated with this maximum were attributed to an overlap
of this band with the positive band of the DNA-CD spectrum.
It was decided, therefore, to examine the behavior of the
CD spectrum of the EB-DNA complex at that wavelength in
conditions under which the positive CD contribution from
nucleic acid is reduced.

Such conditions exist in high salt

concentrations; it has been reported that, in 6.0 M LiCl,
the ellipticity of DNA in the 260 - 290 nm region is
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substantially reduced, with an especially pronounced reduction above 290 nm (Studdert et al., 1972).

We observed

similar, although less drastic, changes in the CD of DNA in
5.0 M NaCl.
The general features of the CD of the EB-DNA complex
are not substantially altered in 5.0 M'NaCl solution
(Figure 31).

Apart from an increase in the ellipticity of

the 375 nm band, both the ellipticities and the maxima of
the other bands located at wavelengths higher than 310 nm
remain unchanged.

In fact, the results listed in Table 3

indicate that ellipticities at 310 nm as well as 500 nm
remain remarkably constant for salt concentrations which
vary between 0.04 and 5.0 M·

Furthermore, examination of

Figure 32 reveals that the dependence of the ellipticities
near 310 nm on bound EB to DNA ratios at 5.0 M NaCl exhibits
a close similarity to the results obtained in 0.04 M buffer.
The only apparent qualitative difference between the spectra
at 0.04 M buffer and 5.0 M NaCl is that in the latter the
negative CD band located near 295 nm is present for all
ethidium bromide to DNA ratios examined, while at the lower
ionic strength this band is present only for high EB to DNA
ratios.
These results suggest that contributions from negative CD in the vicinity of this band may in fact be present.

r
;,,,,,
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Figure 31.

CD spectrum of the EB-DNA complex at an

added EB/nucleotide ratio of 0.1.
5.0 M NaCl, pH 7.9.

Buffer:

0.04 M Tris-HCl,

Ellipticity values for wavelength above

360 run are multiplied by a factor of 10.
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T A B L E

3

Circular dichroism of the EB - DNA complex at
various salt concentrations

El-Er near 310 nm

E 1 -Er near 500 nm

5.2

-0.53

0.12

6.1

-0.41

0.20

6.0

. -0. 46

0.50

6.1

-0.48

0.60

5.4

-0.45

0.75

5.5

-0.41

1.0

6.0

-0.50

.5. 0

5.4

-0.46

NaCl, (M)

Measurements were carried out for samples of added
EB/nucleotide ratios between 0.085 and 0.28, with r values
ranging between 0.085 and 0.14.

El-Er values for the maxi-

mum near 310 nm are reported for an£ of 0.085 and were
estimated from plots of El-Er versus£·

r
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Figure 32.

Dependence of molar ellipticity of the

EB-DNA complex at the band maximum near 310 nm.
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MTris-HCl, 5.0 M NaCl, pH 7.9.
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for low EB to DNA ratios as well but a definite band near
295 nm can be distinguished only at higher ionic strengths
or at higher ratios..
The increase in the CD and the shift in the apparent
maxi.mum of this band from 296 to 292 nm noted with
£ at constant concentration of EB and

~hanging

increa~ing

DNA concentra-

tions (Table 4) may simply be interpreted as the result of
two distinct trends:

the increase in the negative CD origi-

nating from transitions characteristic of the interaction
between DNA and EB and the increase in the overlap between
the CD originating from this interaction with the positive
CD of DNA present at wavelengths below 300 nm.

This overlap

would tend to produce the shift in t he apparent maximum of
the 295 nm band and would limit ellipticities even at the
higher EB to DNA ratios.

However, substantially higher

ellipticities near 295 nm are noted in 5.0
33).

~NaCl

(Figure

This increase is, of course, consistent with the ex-

pected decrease in the contribution of the positive CD of
DNA below 300 nm.
The variations in the ellipticities of the complex
near 295 nm with r noted both at 0.04 M buffer and at 5.0 M
NaCl, when the CD is obtained at constant DNA concentration
(Figure 33, Table 5) deserves some comment.

The only appa-

rent explanation for these results is that the negative CD

r
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T ABL E 4
Dependence of molar ellipticity of the EB-DNA complex
/

near 295 run on £

Added
EB/DNA ratio

A max(nm)

E:

1

-e: r at Amax

0.15

0.15

296

-0.7

0.25
1.00

0.21
0.24

295
292

-1.7

Buffer:

0.04 M Tris-HCl, pH 7.9.

-2.0

r
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Figure 33.
in 0.04
values.

~

The circular dichroism of EB-DNA complex

Tris-HCl, 5.0
Upper curve, £

~.NaCl,

pH 7.9 buffer at various r

= 0.086; middle curve, r = 0.162;

lower curve, £ = 0.180.

2CO

3oo

3IO

.A,nm

31/J
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T A B L E

5

Dependence of molar ellipticitiy of the EB-DNA complex near 295 nm on r

Added
EB/DNA ratio

£

'Amax (run)

E -f. at A
1 r
max

0.10

0.085

297

-3.2

0.20

0.133

296

-3.6

0.40

0.162

295

-5.4

0.50

0.164

295

-5.7

0.65

0.164

295

-6.3

0.80

0.165

294

-6.4

1.00

0.180

294

-7.2

Buffer:

0.04 tl Tris-HCl, 5.0 M NaCl, pH 7.9.
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near 295 run exhibits an intrinsic dependence on the EB/DNA
ratios, increasing as the ratio increases.

The behavior

of the 295 run band appears therefore to be similar to that
noted for the positive CD band near 310 run and distinct from
that of the band centered at 500 run.

This indicates that

the 295- and the 310-run bands may have similar origin.

In

fact, the relationship between these two bands in terms of
both their neighboring positions and the dependence of their
ellipticities on £ strongly suggests that these bands are
manifestations of the positive and the negative CD components
of the same conservative transition (Tinoco, 1964).
The generally lower ellipticities noted for the
negative component and the somewhat asymetric shape of the
doublet are, of course, consistent with the.overlap between
this band and the CD of the DNA below 300. run.
3.

FLUORESCENCE STUDIES
Additional information regarding the conformation of

the DNA-phenanthridinium complex may be obtained from the
study of the effect of DNA binding on the fluorescence
properties of these compounds.

It is known that the fluo-

rescence intensity of.EB increases substantially upon
binding to double-stranded DNA (LePecq et al., 1964),

Fluo-

rescence is a molecular property, the expression of which
depends on such environmental factors as solvent pH,

r

86

J

J

viscosity, polarity etc., as well as the specific geometric
orientation of the fluorescing molecules.

Since the confor-

mation of the DNA-phenanthridiniurn complex is influenced by
the number of primary amino substituents of the intercalated molecule, as indicated by the CD studies presented above,
it was thought interesting to examine the effect of these
substituents on the fluorescence enhancement of the phenanthridiniurn compounds upon binding to DNA.
The effect of DNA on the fluorescence of EB is
illustrated in Figure 34.

The fluorescence increase in the

presence of DNA is very similar to that reported previously (LePecq et al., 1964).

The increase in fluorescence as a

function of the bound dye/nucleotide ratio is shown in
Figure 35.

In this Figure, the net fluorescence per mole of

bound drug, calculated as described in Section 5 (Methods),
is plotted versus £•
As shown in this Figure, the net fluorescence per
mole of bound drug increases approximately 30-fold when all
the drug is intercalated to DNA (low£ values).

The fluo-

rescence values are independent of the concentration of the
complex for low£ values, but later decrease as £increases.
This apparent decrease is probably due to the fact that the
total concentration of bound ethidiurn is used in the calculation of fluorescence.

However, a proportion of bound

EB represents molecules which are attached via electrostatic

r
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Figure 34.

Fluorescence emission spectrum of free

EB (curve A) and EB in the presence of 8.6 x 10- 4 M calf
thymus DNA (curve B).
Excitation wavelength:

(EB)

= 4.6

530 nm.

x 10- 5 Min both samples.
The 530 nm band represents

scattered excitation light.

Ordinate:

tensity in arbitrary units.
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Figure 35.

Dependence of molar fluorescence of the

EB-DNA complex on £·

Excitation wavelength: 530 nm.

Emission wavelength:

590 nm.
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interactions on the outside of the helix and which have a
fluorescence efficiency that is very similar to that of the
free drug (LePecq and Paoletti, 1967).

Since the propor-

tion of these bound molecules increases with increasing r,
it is reasonable to expect a decrease in the average fluorescence intensity per mole of bound drug.
Similar results were obtained with the DDMB-DNA complex (Figure 36).

Again, an increase in fluorescence inten-

sity of approximately 20-fold is observed upon binding of
the drug to the nucleic acid.
A distinctly different picture, however, emerges from
the interaction of monoamino compounds with DNA.

A represen-

tative emission spectrum of MAPAC in the presence and absence
of DNA is shown in Figure 37.

As indicated in this Figure,

the fluorescence of MAPAC does not increase very much upon
binding to DNA.
The dependence of the fluorescence of MAPAC and MAPEC
on the bound dye/nucleotide ratio is shown in Figures 38 and
39.

Because of the very low fluorescence intensity of these

compounds, the experimental error of the measurements presented in Figures 38 and 39 may be considerable.

It is evi-

dent, nevertheless, that a fluorescence enhancement, similar
to that observed in the case of the diamino derivatives,
does not take place.
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Figure 36.

Dependence of molar fluorescence of the

DDMB-DNA complex on r.

Excitation wavelength:

580 nm.

Emission wavelength:

Buffer:

517 nm.
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pH 7.9.
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Figure 37.

Fluorescence emission spectrum of free

MAPAC (curve A) and MAPAC in the presence of 8.6 x 10- 4 M
calf thymus DNA (curve B).
cases.

(MAPAC)

Excitation wavelength:

=

3.6 x 10- 5

470 nm.

rescence intensity in arbitrary units.
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Figure 38.

Dependence of molar fluorescence of the

MAPEC-DNA complex on £·

Excitation wavelength: 470 nm.

Emission wavelength: 555 nm.
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MTris-HCl,

pH 7.9.
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Figure 39.

Dependence of molar fluorescence of the

JvIAPAC-DNA complex on r.

Excitation wavelength: 470 nm.

Emission wavelength: 560 nm.
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MTris-HCl,
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In the case of another monoamino phenanthridinium
drug, MMPB (Figure 40), fluorescence per mole of DNA-bound
drug does increase, approximately 5-fold, upon binding of
the drug to DNA.

This, however, is a relatively small in-

crease, compared with the 20- to 30-fold increase exhibited
by the diamino compounds, and, in any case, the resulting
fluorescence intensity is less than 1/20 of the corresponding intensity observed with the diamino compounds.
It appears, therefore, that the effect of DNA binding on the fluorescence intensity of the phenanthridinium
drugs is quite distinct for the monoamino derivatives than
it is for the diamino compounds.

This differential effect

may be another reflection of the conformational differences,
already suggested by the CD experiments, between the two
classes of complexes.

These conformational differences are

expected to influence the interactions of the intercalated
dyes with their molecular environment and, consequently, may
be responsible for the observed differences in fluorescence
intensity.
4.

TEMPERATURE - OPTICAL DENSITY PROFILES
Several intercalating compounds, including EB, have

been shown to increase the melting temperature of DNA
(Kleinwachter and Koudelka, 1964; Gersch and Jordan, 1965;
Waring, 1974).

However, no systematic study has been
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Figure 40.

Dependence of molar fluorescence of the

MMPB-DNA complex on £•
Emission wavelength:

Excitation wavelength:
560 nm.
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475 nm.

0.04 M Tris-HCl,

pH 7.9.
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undertaken to determine the relationship, if any, between
the chemical structure of the intercalating molecule, as
expressed in the conformation of the resulting complex, and
the thermal stability of the complex.

Such information is

useful in understanding the nature of forces involved in
stabilizing the dye-DNA complex, as well as evaluating the
effect of the phenanthridinium dyes on the activity of enzymes, such as DNA polymerase, the action of which requires
that DNA be in the single-stranded form.
The effect of the various substituents of the phenanthridinium ring on the stability of the DNA-phenanthridinium
complexes was studied by means of the temperature-optical
density profiles (Tm profiles) of these complexes.

The

I
~

i

phenanthridinium compounds used in this study were:
DDMB, MAPEC, MAPAC and MMPB.

EB, DEMB,

The temperature-optical density

profiles at 260 nm were obtained as described in Section· 6
(Methods), using samples with an added dye to nucleotide
ratio of 0.10.
The melting profiles of DNA alone and of DNA complexed with each of the above phenanthridinium compounds are
illustrated in Figures 41-47 and the results are summarized
in Table 6.

The melting profiles are plotted as normalized

(or total) hyperchromicity versus temperature.
The initial gradual increase in absorbance, observed
for all drug-DNA complexes before the onset of the melting
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Figure 41.

Temperature-optical density profile at
(DNA)= 1.5 x 10- 4

260 nm of calf thymus DNA.
rate:

3°C/min.
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0.04

MTris-HCl,

M·

Heating

pH 7.9.

100

DNA

~ 80
>;

-·0

E

60

...0

.c
0

I.

40

Q)

a.

>.

I: 20

0

20

40

60

T emperature,

80

oc

100

r

98
Figure 42.

Temperature-optical density profile at

260 nm of the MAPEC-DNA complex. (MAPEC) = 1.5 x 10- 5 M.
4
(DNA) = 1.5 x io- M· Heating rate: 3°C/min. Buffer:
0.04 M Tris-HCl, pH 7.9.
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Figure 43.

Temperature-optical density profile at
260 nm of the MAPAC-DNA complex. (MAPAC) = 1.5 x 10- 5 M.
(DNA)= 1.5 x 10- 4 M· Heating rate: 3°C/min. Buffer:
0.04 M Tris-HCl, pH 7.9.
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Figure 44.

Temperature-optical density profile at
260 nm of the MMPB-DNA complex. (MMPB) = 1.5 x 10- 5 M.
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer:
0.04 M Tris-HCl, pH 7.9.
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Figure 45.

Temperature-optical density profile at

260 nm of the EB-DNA complex. ( EB ) = 1.5 x 1 0 -5 M·
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer:
0.04

MTris-HCl,

pH 7.9.
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Figure 46.

Temperature-optical density profile at
260 nm of the DEMB-DNA complex. (DEMB) = 1.5 x 10- 5 M·
(DNA)= 1.5 x 10- 4 M. Heating rate: 3°C/min. Buffer:
0.04

MTris-HCl,

pH 7.9.
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Figure 47.

Temperature-optical density profile at
260 nm of the DDMB-DNA complex. (DDMB) = 1.5 x 10- 5 M.
(DNA)= 1.5 x io- 4 M· Heating rate: 3°C/min. Buffer:
0.04

MTris-HCl,

pH 7.9.
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TABLE

6

The effect of certain phenanthridiniurn compounds on
the thermal stability of DNA

Compound

Tm (°C)

None

AT30- 1o<Oc)

76. 5

5.5

EB

83.2

7.0

DEMB

83.8

7.0

DDMB

85.5

4.5

MAPEC

84.5

7.5

MAPAC

82.8

7.0

MMPB

82.8

7.0

Diamino:

Monoamino:

Buffer:

0.04 M Tris-HCl, pH 7.9.

Heating rate: 3°C/min. (DNA)

=

1.5 x l0-4M.

Light path: 1.0 cm.
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transition, is probably due to the decrease in drug binding
with increasing temperature (Results, Section 1.3).

Since

the binding of the dye to DNA is accompanied by a hypochromic effect, the release of bound drug would be expected
to result in an increase in absorbance.
The effects of the phenanthridinium derivatives on
the melting of DNA may be summarized as follows:
A.

The phenanthridinium compounds tested increase

the thermal stability of the double-helical form of the DNA.
Similar observations have been made previously for a number
of intercalating agents, including EB (Kleinwachter and
Koudelka, 1964; Gersch and Jordan, 1965; LePecq and Paoletti,

1967).
B.

All derivatives tested, whether ,mono- or diamino,

increase the melting temperature of DNA to approximately the
same extent, namely from 76.5°c to an average of 83.8°C.

It

has been reported that in the case of EB as well as of other
intercalating compounds, such as acridines, the Tm is very
sensitive to the added drug to nucleotide ratio at low values
of this ratio (Kleinwachter and Koudelka, 1964; Gersch and
Jordan, 1965; Waring, 1974).

Therefore, the small differen-

ces observed in the presence of different phenanthridinium
derivatives may simply be due to potential experimental
error in determining the concentration of the drug.

106
C.

The width of the melting transition, as measured

by .b.T 30 _70 , increases from 5.5°C, in the case of DNA, to
approximately 7.0°c for the dye-DNA complexes.
The significance of these findings, in terms of the
stability and conformation of the phenanthridiniurn-DNA cornplexes, is examined in subsequent chapters.
5.

INHIBITION OF DEOXYRIBONUCLEASE
A study of the inhibition of DNase by phenanthridi-

niurn compounds was undertaken in order to examine further
the effect of the chemical structure of the intercalated drug
on the conformation of the drug-DNA complex.

Enzymes, in

general, and DNase I, in particular, have specific conforrnational requirements for their substrates.

Therefore, any

factor affecting substrate conf orrnation would also be expected to have an effect on the activity of the enzyme.
More specifically, the inhibition of DNase I activity
on native DNA by EB, DDMB, MAPEC and MAPAC was studied.

The

dependence of the inhibition of the enzyme on the added drug/
nucleotide ratio for these four drugs is shown in Figures
48 - 51.

Since the amount of DNA present in all complexes

is the same, this presentation of the data is equivalent to
one where percent inhibition is plotted versus total amount
of inhibitor present.
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Figure 48.

Inhibition of pancreatic DNase by EB as a

function of the added EB/nucleotide ratio.
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Figure 49.

Inhibition of pancreatic DNase by DDMB

as a function of the added DDMB/nucleotide ratio.
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Figure 50.

Inhibition of pancreatic DNase by MAPEC

as a function of the added MAPEC/nucleotide ratio.
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Tris-HCl, 0.004 M MgS04, 0.0017 tl CaClz, pH 7.9.
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Figure 51.

Inhibition of pancreatic DNase by MAPAC

as a function of the added MAPAC/nucleotide ratio.

Buffer:

0.04 M Tris-HCl, 0.004 tl MgS0 4 , 0.0017 M CaC1 2 , pH 7.9.
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Examination of the dependence of DNase inhibition on
the added dye/nucleotide ratio reveals the presence of some
differences in the inhibition effects of the phenanthridiniurn
derivatives used in this study.

However, no definite con-

clusions can be drawn as to the differences in the effectiveness of these compounds as inhibitors without a knowledge of
the mechanism whereby this inhibitory action is brought
about.

For this reason the question whether EB interferes

with the substrate function of DNA or whether it affects the
activity of the enzyme itself was investigated.
Figure 52 shows the results of an experiment, in
which the enzyme activity was studied as a function of DNA
concentration, either in the absence or in the presence of
EB.

The results are plotted according to Lineweaver and

Burk (Lineweaver and Burk, 1934) as the inverse of the initial velocity versus the inverse of the substrate concentration.

Experimental points obtained either in the presence

or in the absence of inhibitor fall on straight lines intersecting each other on the ordinate.

This observation indi-

cates that the inhibition of DNase by these phenanthridiniurn
compounds is related in a competitive fashion to the amount
of DNA present and serves as strong evidence in support of
the notion that EB has no effect on the enzyme itself, but
rather interferes with the function of DNA as substrate.

r
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Figure 52.

Effect of the variation of the concen-

tration of DNA substrate on the activity of pancreatic DNase
6
in the absence (0) and in the presence of 2.7 x 10- M EB

(1).

Buffer:

0.04 M Tris-HCl, 0.004 M MgS0 4 , 0.0017 M

CaC1 , pH 7.9.
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Further support for this mechanism of inhibition is
provided by the observation that, when total inhibitor concentration, Dt, is plotted versus the inhibition function
i/1-i, the experimental points can easily be fitted to a
curve which passes through the origin of the axes and the
initial and final parts of which are straight lines (Figures
53 - 56).

This behaviour corresponds exactly to the case

where the inhibitor binds to the substrate at the same site
as the enzyme; the inhibition is the result of a diminution
of the number of substrate molecules susceptible to an attack
by the enzyme (Reiner, 1959).

From the values of the slopes

of the two linear portions and the extrapolative intercept
on the Dt axis, the association constants for the binding of
the phenanthridinium drugs to DNA were calculated.

These

values are summarized in Table 7 along with the spectrophotometrically (Results, Section 1.3) determined values.

There

is remarkable agreement between t he two sets of association
constants determined by the two methods.
In view of the observation that DNase inhibition
appears to be due to the binding of the phenanthridinium inhibitors to the DNA substrate, perhaps a more meaningful way
of presenting the data is in the form of dependence of inhibition on the amount of drug bound to DNA or, equivalently,
on £·

The amount of drug bound to DNA was calculated on the

basis of the binding constants obtained in 0.04 M potassium
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Figure 53.

Inhibition of pancreatic DNase by EB.

The data are plotted according to (Reiner, 1959).
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Figure 54.

,;

Inhibition of pancreatic DNase by DDMB.

The data are plotted according to (Reiner, 1959).
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Figure 55.

Inhibition of pancreatic DNase by

The data are plotted according to (Reiner, 1959).
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Figure 56.

Inhibition of pancreatic DNase by MAPAC.

Ihe data are plotted according to (Reiner, 1959).
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T ABL E 7
Association constants for the binding of certain
phenanthridinilllTI cOmpounds to DNA

Compound

Reiner plot(l)

Scatchard plot( 2 )

MAPAC

2.2 x 10 5 1/mole
2.6 x 10 5 1/mole
1.2 x 10 5 1/mole

2.2 x 105 1/mole
1.9 x 10 5 1/mole
1.7 x 10 5 1/mole

MAPEC

1.6 x 10 5 l/mole

2.0 x 105 1/mole

EB
DDMB

(l)Buffer:
( 2 )Buffer:

0.04 M Tris-HCl, 4 mM MgS0 4 , 1.7 mM CaC1 2 , pH 7.9.
0.04 M potassilllTI phosphate, 8 mM MgC1 2 , pH 7.0.

119
phosphate, 0.008 M MgC1 2 , pH 7.0.

Although these are not

the exact conditions under which the DNase assay was performed, these binding constants are nevertheless very close to
the values obtained under assay conditions (Table 7).
The percent inhibition of DNase by phenanthridinium
dyes, as a function of£, is shown in Figures 57-60.

Certain

features of these graphs deserve comment.
The inhibition of DNase increases rapidly up to an
r of approximately 0.025 which corresponds to about 25%
inhibition of the enzyme activity.

Beyond that point, the

inhibition increases linearly with the concentration of
DNA-bound drug with slopes that are similar for the four
drugs tested.

Small differences, however, may exist and

they seem to indicate that a phenyl substituent at position
6 (EB, MAPEC, MAPAC with slopes, respectively, or 548, 535,
and 545) gives rise to more effective DNase inhibition than
the 6-methyl substituent (DDMB with a slope of 498).
The number of amino substituents on the phenanthridinium ring apparently does not affect substantially the inhibitory effect of these compounds on the activity of DNase,
as it is evident from a comparison of the slopes of the
inhibition plots of a diamino compound (EB, slope
and two monoamino compounds (MAPEC, slope
slope= 545).

= 548)

= 535 and MAPAC,
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Figure 57.
a function of£·
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Figure 58.
as a function of£·

Inhibition of pancreatic DNase by DDMB
Buffer:

0.0017 M Cac1 , pH 7.9.
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Figure 59.

Inhibition of pancreatic DNase by MAPEC

as a function of r.
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Figure 60.
as a function of r.

Inhibition of pancreatic DNase by MAPAC
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6.

INHIBITION OF DNA POLYMERASE
Additional information concerning the effect of the

intercalated phenanthridinium drug on the conformation and
stability of the DNA-drug complex can be obtained from the
study of the effect of these compounds on the activity of
DNA polymerase using this complex as template.

Changes in

the conformation of the DNA-dye complex due to intercalation
of different phenanthridinium dyes are expected to alter
the affinity of the enzyme for the template and result in
altered overall enzymic activity.

Furthermore, physical

separation of the parent strands is known to be a pre-requisite for DNA replication.

Agents stabilizing the double-

stranded conformation of the DNA are expected to have an
overall inhibitory effect on the action of DNA polymerase.
Therefore, since phenanthridinium drugs preferentially
stabilize the double-helical form of DNA (Results, Section
4), it appeared to be of interest to examine whether their
DNA-stabilizing effect could be correlated with their inhibitory action on DNA polymerase.
The effect of four phenanthridinium compounds on
the activity of the Micrococcus luteus
studied.

The compounds used were:

DNA polymerase was

EB, DEMB, MAPEC and MAPAC.

Initially, the amount of new DNA synthesis was studied as a function of the time of incubation of the assay

125
mixture at 37°C.

As evidenced from the results shown in

Figure 61, the amount of DNA synthesized is directly proportional to the incubation time, at least up to 40 min.

In

subsequent experiments, incubation time was limited to 30
min.
The percent inhibition of DNA polymerase as a function of the added dye/nucleotide ratio is shown in Figures
62 - 65.

For all four drugs tested, the inhibition increases

very rapidly for low added ratios, but appears to level off
after a ratio of, about, 0.25.

At this value, approximately

80% inhibition of the polymerase activity is observed.
Of course, no definite comparison between the inhibitory action of these phenanthridinium compounds on DNA
polymerase activity is possible without

som~

knowledge of

the mechanism of their action and, specifically, without
knowing whether the inhibition of the polymerase activity
is due to the interaction of the inhibitor with the DNA ternplate or with the enzyme itself.

In order to answer this,:

question, four experiments were carried out, in which the
amount of new DNA synthesized was studied as a function of
the concentration of the DNA template, both in the absence
and in the presence of phenanthridinium inhibitors.

The

results were plotted according to Lineweaver and Burk as the
inverse of the amount of newly synthesized DNA versus the
inverse of the concentration of the template and are shown
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Figure 61.

Time dependence of DNA synthesis by

Micrococcus luteus DNA polymerase I.

The reaction mixture

contained, in 0.3 ml, 0.04 M potassium phosphate, pH 7.0;
0.008 M MgC1 2 ; 0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol;
0.1 mtl each of dATP, dGTP, dCTP; 0.1 mM of tritiated TIP
(approximately 15000 cpm/nmole); 8 µg/ml enzyme; temperature:

37°c.
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Figure 62.

Inhibition of DNA polymerase by EB as a

function of the added EB/nucleotide ratio.

The reaction

mixture contained, in 0.3 ml, 0.04 M potassium phosphate,
pH 7.0; 0.008 M MgC1 2 ; 0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mM

each of dATP, dGTP, dCTP; 0.1

mM

of tritia-

ted TIP (approximately 15000 cpm/nmole); 8 µg/ml enzyme;
0.072 mg/ml activated calf thymus DNA.

Temperature: 37°c.
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Figure 63.

Inhibition of DNA polymerase by DEMB as

a function of the added DEMB/nucleotide ratio.
mixture contained, in 0.3 ml, 0.04

The reaction

M potassium phosphate,

pH 7.0; 0.008 M MgC1 2 , 0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mtl each of dATP, dGTP, dCTP; 0.1 mM of tritiated
TTP (approximately 15000 cpm/nmole); 8 µg/ml enzyme; 0.072
mg/ml activated calf thymus DNA.

Temperature: 37°C.
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Figure 64.

Inhibition of DNA polymerase by MAPEC as

a function of the added MAPEC/nucleotide ratio.

The reaction

mixture contained, in 0.3 ml, 0.04 M potassium phosphate,
pH 7.0; 0.008 M MgC1 2 ; 0.33 mg/ml BSA; 0.001

M2-mercapto-

ethanol; 0.1 mM·each of dATP, dGTP, dCTP; 0.1 mM of tritiated TTP (approximately 15000 cpm/nmole); 8 µg/ml enzyme;
0.072 mg/ml activated calf thymus DNA.

Temperature: 37°C.
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Figure 65.

Inhibition of DNA polymerase by MAPAC as

a function of the added MAPAC/nucleotide ratio.
mixture contained, in 0.3 ml, 0.04

Mpotassium

The reaction
phosphate,

pH 7.0; 0.008 tl_MgCl2; 0.33 mg/ml BSA; 0.001 M
2-mercaptoethanol; 0.1 mM each of dATP, dGTP, dCTP; 0.1 rnM
of tritiated TIP (approximately 15000 cpm/nrnole); 8 µg/ml
enzyme; 0.072 mg/ml activated calf thymus DNA.
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in Figures 66 - 69.

With all four compounds studied,

straight lines can be drawn through the experimental points
obtained both in the presence and in the absence of inhibitor.
These two lines intersect each other on the l/v axis, thus
indicating that the inhibition of DNA polymerase by these
phenanthridinium compounds is competitive with the concentration of the DNA template.

This finding is in complete

agreement with, and further supports, the notion that the
inhibitory effect of these compounds on DNA polymerase is
due to the formation of a complex between the dyes and the
template.

A similar observation was reported (Waring, 1965a)

for the inhibition of the DNA-dependent RNA polymerase activity by EB, indicating a similar mode of inhibition of the
two enzyme systems by EB.
Since the DNA polymerase inhibition seems to result
from the interaction of the drug with the template, a more
meaningful way of presenting the inhibition data is, perhaps,
as a function of the template-bound inhibitor or, equivalently, as a function of r (Figures 70 - 73).

The amount of

template-bound drug is estimated by means of the binding
constants obtained under assay conditions (Results, Section
1.3).

The inhibition of DNA polymerase by the four phenanthridinium drugs tested depends very strongly on the concentration of the DNA-drug complex and, at low r values 9

r
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Figure 66.

Effect of the variation of the concen-

tration of DNA template on the activity of DNA polymerase in
6
the absence (4) and in the presence of 4.3 x 10- M EB (~).
The reaction mixture contained, in 0.3 ml, 0.04

~

potassium

phosphate, pH 7.0; 0.008 ~ MgC1 2 ; 0.33 mg/ml BSA; 0.001 M
2-mercaptoethanol; 0.1 mM each of dATP, dGTP, dCTP; 0.1 mM
of tritiated TIP (approximately 15000 cpm/nmole); 8 µg/ml
0

enzyme; temperature: 37 C.
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Figure 67.

Effect of the variation of the concen-

tration of DNA template on the activity of DNA polymerase in
the absence (~) and in the presence of 6 x 10- 6 M DEMB (~).
The reaction mixture contained, in 0.3 ml, 0.04 M potassium
~

phosphate, pH 7.0; 0.008
2-mercaptoethanol; 0.1

MgC1 2 ; 0.33 mg/ml BSA; 0.001 M

rnM each of dATP,· dGTP, dCTP; 0.1

rnM

of tritiated TIP (approximately 15000 cpm/nmole); 8 µg/ml
enzyme; temperature: 37°c.
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Figure 68.

Effect of the variation of the concen-

tration of DNA template on the activity of DNA polymerase in
the absence (A) and in the presence of 4.5 x 10- 6 M
MAPEC (6).

.

The reaction mixture contained, in 0.3 ml,

0.04 M potassium phosphate, pH 7.0; 0.008 M MgC1 2 ;
0.33 mg/ml BSA; 0.001 M 2-mercaptoetha~ol; 0.1 mM each of
dATP, dGTP, dCTP; 0.1 mM of tritiated TIP (approximately

15000 cpm/nmole); 8 µg/ml enzyme; temperature: 37°c.
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Figure 69.

Effect of the variation of the concen-

tration of DNA template on the activity of DNA polymerase in
the absence (A) and in the presence of 6 x 10- 6 M MAPAC (A).
The reaction mixture contained, in 0.3 ml, 0.04 M potassium
phosphate, pH 7.0; 0.008

~

MgC1 2 ; 0.33 mg/ml BSA; 0.001 M

2-mercaptoethanol; 0 .1 mM each of dATP '· dGTP, dCTP; 0 .1 mM
of tritiated TTP (approximately 15000 cpm/nmole); 8 µg/ml
enz:Yme; temperature:

37°C.
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Figure 70.
a function of
0.04

Inhibition of DNA polymerase by EB as
The reaction mixture contained, in 0.3 ml,

.£•

Mpotassium

phosphate, pH 7.0; 0.008

MMgC1 2 ;

0.33 mg/ml BSA; 0.001 M 2-mercaptoethanol; 0.1 mM each of
dATP, dGTP, dCTP; 0.1 mM of tritiated TTP (approximately
15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated
calf thymus DNA.

Temperature:

37°c.
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Figure 71.
a function of £·
0.04

Mpotassium

Inhibition of DNA polymerase by DEMB as
The reaction mixture contained, in 0.3 ml,

phosphate, pH 7.0; 0.008

BSA; 0.001 M 2-mercaptoethanol; 0.1

MMgC1 2 ;

0.33 mg/ml

raM each of dATP, dGTP,

dCTP; 0.1 mtl of tritiated TIP (approximately 15000 cpm/nmole);
8 pg/ml enzyme; 0.072 mg/ml activated calf thymus DNA.
Temperature: 37°c.
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Inhibition of DNA polymerase by MAPEC

Figure 72.

The reaction mixture contained, in

as a function of r.

0.3 ml, 0.04 M potassium phosphate, pH 7.0; 0.008 M MgC1 2 :
0.33 mg/ml BSA; 0.001

2-mercaptoethanol; 0.1 mt! each of

~

dATP, dGTP, dCTP; 0.1 m~ of tritiated TIP (approximately
15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated
calf thymus DNA.

Temperature: 37°C.
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Figure 73.

Inhibition of DNA polymerase by MAPAC

as a function of £·

The reaction mixture contained, in

0.3 ml, 0.04 M potassium phosphate, pH 7.0; 0.008 M MgC1 ;
2
0.33 mg/ml BSA; 0.001 tl 2-mercaptoethanol; 0.1 mM each of
dATP, dGTP, dCTP; 0.1

~of

tritiated TTP (approximately

15000 cpm/nmole); 8 µg/ml enzyme; 0.072 mg/ml activated calf
thymus DNA.

Temperature:

37°c.
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it increases rapidly with r so that the activity of the
polymerase is already reduced by 50% at an £ value of
approximately 0.05,. i.e.

when, on the average, one drug

molecule is bound per 10 base pairs.

However, at higher

concentrations of the DNA-drug complex, the rate of inhibition gradually decreases and certain differences in the
inhibitory effect of these drugs on DNA polymerase activity
become apparent.

Indeed, 90% inhibition with MAPEC is

observed at an £ value of 0.13, with MAPAC at an r of 0.14
and with EB at an r of 0.15, whereas with DEMB, such level
of inhibition is not observed until an£ of 0.18 is reached.
It is interesting to note that DEMB, the compound that
appears as the weakest inhibitor, is the only one among the
four derivatives studied in which the 6-phenyl substituent
has been replaced by a relatively smaller ethyl group.
This observation suggests that the size of the substituent
at position 6 of the phenanthridinium ring plays some role
in determining the extent of DNA polymerase inhibition by
the phenanthridinium compounds.

r
DISCUSSION
1.

FACTORS INFLUENCING THE STABILITY OF THE COMPLEX
It is generally accepted that intercalation of

phenanthridinium compounds to DNA places the phenanthridinium
ring between two successive base pairs 'in an orientation
approximately perpendicular to the helix axis.

Stabilization

energy for the formation of this complex is provided mainly
by hydrophobic forces between the phenanthridinium ring and
the DNA bases.

Additional stabilization is afforded by

hydrogen bonds formed between the amino substituents at positions 3 and 8 of the intercalated molecule and the phosphate
groups at the two DNA strands.
The above model, proposed initially for EB (Fuller
and Waring, 1964), appears to be equally valid for the rest
of the phenanthridinium compounds examined in this investigation.

Indeed, measurements of the unwinding angle of

supercoiled DNA in the presence of phenanthridinium derivatives suggest that the absence of one or even both amino
groups at positions 3 and 8 of the ring does not affect
appreciably the ability of these compounds to intercalate
(Wakelin and Waring, 1974).

The major component of the

energy of formation of the phenanthridinium-DNA complex is
derived from the hydrophobic interactions mentioned above,
as indicated by the effect of the phenanthridinium derivatives
141
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on the thermal stability of the DNA.

On the basis of the

evidence obtained from the binding studies, it appears that
the extent of double-stranded DNA stabilization against
thermal denaturation is the same for derivatives with the
amino groups at both the

c3 and c8 positions of the ring,

as well as for those with only the 8-amino substituent.

The

absence of any differential stabilization of the complex by
mono- or diamino-phenanthridinium derivatives indicates that
a hydrogen bond between the 3-amino group of the intercalated
molecule and a DNA phosphate residue does not contribute significantly to the overall stabilization of the complex, at
least at melting temperatures.

Indeed, it was estimated

(Wakelin and Waring, 1974) that each of the two hydrogen
bonds (involving the 3- and 8-amino groups of the molecule)
contributes approximately 0.85 kcal/mole to the stability
of the complex.

A contribution of 0.7 kcal/mole for the·

hydrogen bond involving the 3-amino group may be calculated
from the association constant values of EB and MAPEC
(Table 1), with the assumption that the 2- amino group of
MAPEC does not affect the stability of the complex.

Clearly,

such small differences in the free energy of formation of
the complex are not expected to result in any measurable
differential effect on the melting temperature of the
phenanthridinium-DNA complex.
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Small differences in complex stabilizing energy are
more easily detectable at lower temperatures. Indeed, such
differences are expressed in the association constant values
calculated for the binding of the phenanthridinium compounds
to DNA.

Although, at any one set of experimental conditions

used, major differences in the binding 'properties of the
drugs were not observed, small differences do exist, both in
the intrinsic association constant and in the number of
binding sites.

Significantly, these differences are more

pronounced under conditions of low temperature and low ionic
strength, whereas at 37°C and moderately high ionic strength
the association constants are almost the same for both monoand diamino derivatives.

These observations are consistent

with the model of Fuller and Waring presented above and indicate that hydrogen bonds between the 3 and 8 amino groups
of the phenanthridinium molecule and the DNA phosphates contribute a small but measurable fraction of the complex
stabilizing energy.

Therefore, the slightly weaker binding

of the monoamino derivatives can be explained by their lack
of the amino group at position c 3 which would provide the
opportunity for a second hydrogen bond with DNA.
Another interesting feature of the Tm profiles of
the dye-DNA complexes is the observed increase in the width
of the transition
acid.

u~on

binding of the drugs to the nucleic .

This widening of the melting transition is consistent
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with the "reintercalation" mechanism proposed earlier
(Aktipis et al., 1975).

It was observed that, during ther-

mal denaturation of the EB-DNA complex, the molar ellipticity at 310 nm increases sharply shortly after the onset of
strand separation.

This increase was interpreted as indica-

tive of reintercalation of EB molecules that had been
released from the already melted regions of the complex.
It may be assumed that, at room temperature, the EB molecules are randomly and uniformly distributed over the length
of the DNA molecule.

As the temperature is increased, how-

ever, certain regions of DNA tend to melt first.

EB mole-

cules intercalated in these regions are released and reintercalate at more stable DNA regions which retain their
double-stranded form at this temperature.

This process of

rearrangement of intercalated molecules results in a localized increase of the drug/nucleotide ratio.

Since the .

thermal stability of the DNA increases with the increasing
EB/nucleotide ratio (Martz, 1971; Waring, 1974), it is expected that the intercalation of these drug molecules to
the as yet unmelted DNA regions will stabilize these regions
further.

The net result would be widening of the melting

transition of the phenanthridinium-DNA complex as compared
with the breadth of the transition of free DNA.
Alternatively, the widening of the melting transition of the DNA-dye complex may be considered as an indication of the distribution of the intercalated molecules over
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the DNA helix.

In the conditions under which the Tm experi-

ments were performed there is, on the average, one dye molecule bound per five base pairs.

The base pairs in the

immediate vicinity of the intercalated molecule, i.e.

the

ones immediately above and below it, will be the most
stabilized and, therefore, will melt at a temperature significantly higher than their respective melting temperature
in free DNA.
However, because of the cooperative character of the
melting of the DNA, the base pairs between, but not in the
immediate vicinity of, two intercalated dye molecules will
also be stabilized, although to a lesser degree.

This

differential stabilization would, of course, result in
differences in the melting temperatures of the various groups
of base pairs and these differences could be reflected in
the widening of the overall melting transition of the dyeol

DNA complex.
2.

INFORMATION ON THE CONFORMATION OF THE COMPLEX OBTAINED

BY PHYSICAL METHODS
As already indicated in the Introduction, one of the
major goals of this investigation concerns the relationship
between the chemical structure of the intercalated phenanthridinium derivatives and the conformation of the

146

phenanthridinium-DNA complex.

Specifically, the conforma-

tion of the complex is examined as a function of the primary
amino groups at positions 3 and·8 of the dye molecule.

In-

formation concerning the conformation of the phenanthridiniurn-DNA complex presented in this dissertation is derived
mainly from the results of the circulaE dichroism and fluorescence experiments.
2.1.

Differences in the origin of the CD bands of the complex
Circular dichroism, as a phenomenon, expresses the

differential absorption of right and left circularly polarized light by an optically active chromophore.

Since cir-

cular dichroism is a result of differences in absorption of
light, it is observed in the vicinity of the absorption bands
of the compound under study.

The wavelength, therefore, at

which the optical activity of a chromophore is manifested,
is determined inherently by the molecular structure of that
chromophore.

Optical activity may be inherent in the chromo-

phore, because of its intrinsic configuration, or, alternatively, it may be induced by an asymmetric environment in a
chromophore which is, by itself, optically inactive.
The circular dichroism observed in the 300-600 nm
region when phenanthridiniurn drugs bind to DNA is of the
second type of optical activity discussed above, namely induced optical activity.

The DNA molecule alone, despite its
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structural assyrnmetry, does not display any optical activity
at wavelengths longer than 300 nm, because absorption of
light by this macromolecule is insignificant in this region.
Similarly, the phenanthridinium drugs studied, despite the
presence of strong absorption bands in the wavelength region
between 300 and 600 nm, are not intrinsically asymmetric and
are, therefore, optically inactive.
Consequently, the ellipticity observed when phenanthridinium compounds bind to DNA may be the expression of ,
optical activity induced in the optically inactive chromophore of the bound dye by the asymmetric environment of the
nucleic acid (Yamaoka and Resnik, 1966).

Alternatively, the

possibility exists, especially at high bound drug/nucleotide
ratios, that interactions among the intercalated dye molecules produce or contribute to the optical activity of the
complex (Gardner and Mason, 1967).
Since the CD properties of the DNA-phenanthridinium
complexes in the short (300 - 315 nm) wavelength region are
radically different from those noted in the long (470 - 500
nm) wavelength region, bands with maxima in these two regions
must be attributed to different sources of asymmetry.
Specifically, the characteristics of the long wavelength band, i.e. appearance of optical activity even at low
bound drug/nucleotide ratios and independence of the molar
ellipticity from this ratio, suggest that ellipticity at this
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region is not influenced by the distance between intercalated molecules.

It appears, therefore, that optical activity

in the 470-500 nm region is the result of interactions of the
first type described above, i.e. optical activity in this
region results from the influence of the surrounding asymmetric polynucleotide structure on the intercalated molecule.
In contrast, the ellipticity at the short (300-315 nm)
wavelength band exhibits a behavior which indicates a distinctly different origin.

Specifically, the increase of

molar ellipticity of the diamino drug-DNA complexes at 310 nm
with increasing £ indicates that each bound dye molecule
contributes more to the optical activity when the intercalated molecules are more densely distributed over the DNA
helix.

Therefore, ellipticity at 310 nm appears to originate

from the second type of interaction described above, namely
interactions between dye molecules intercalated at neighboring sites.
2.2.

The origin of the 310 nm CD band
Because of this unusual behavior of the molar ellip-

ticity at 310 nm, the origin of the 310 nm band was investigated in more detail.
A similar dependence of molar ellipticity on dye/
nucleotide ratio was observed in the proflavine-DNA system
and two possible mechanisms were proposed to explain the
phenomenon:
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1.

The increase in molar ellipticity is the result

of direct interactions between intercalated dye molecules.
The possibility of such interaction, of course increases as
the number of molecules bound within a given segment of the
DNA increases (Blake and Peacocke, 1967).
2.

Alternatively, the variation in optical activi-

ty may be due to an alteration of the conformation of the
drug binding site, resulting from intercalation of additional dye molecules at neighboring sites (Dalgleish et al.,
1969).

In this case also, the probability of a dye mole-

cule intercalating to a site adjacent to one already occupied by another molecule increases as the number of bound
dye molecules per, nucleotide increases.
All currently available experimental evidence is
compatible with either one of the above models, so that
elimination of one in favor of the other is not possible,,
at this time. 'In fact, the lack of theoretical predictions
as to the characteristics of the CD resulting from the
second type of interactions renders that model inaccessible
to direct experimental verification.

In contrast, according

to Tinoco (Tinoco, 1964), direct interactions between the
intercalated dye molecules which form a helical array are
expected to give rise to a doublet of positive and negative
peaks in the CD spectrum.

In fact, there is an indication
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of such a doublet centered at approximately 300 nm in the CD
spectrum of the EB-DNA complex (Figures 16 and 31).

The

negative component of this probable doublet is not easily
detectable at low ionic strength, probably because of a
mutually cancelling effect between this band and the strong
positive band of the DNA spectrum at 270 nm.
The existence of the conservative doublet in the CD
spectrum of the EB-DNA complex lends support to the notion
that direct interactions between EB molecules intercalated
at neighboring sites are important contributors to the CD
of the complex in the 300 nm region at high ionic strength.
Furthermore, this conclusion may be expanded to low ionic
strength conditions if it is assumed that the conformation
of the complex is not significantly affected by increased
salt concentration.

There are indeed indications that, aside

from a minor change in the average angle of rotation of the
helix, the conformation of the DNA is not particularly sensitive to salt (Wang, 1969; Studdert et al., 1972).
larities

of

the CD of the complex in 0.04

MTris

The simiand in

5.0 M NaCl indicate that a similar condition may apply to the
EB-DNA complex.
Another question which may be considered is whether
these interactions between dye molecules intercalated at
adjacent sites are transmitted through the intervening base
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base pairs or whether they occur in some other more direct
manner.

According to the original intercalation model

(Fuller and Waring, 1964), the phenanthridinium ring is
completely immersed in the space between the base pairs and
no part of it is accessible for direct interactions between
intercalated molecules.

The model, however, postulates that

the 5- and 6-substituents of the drug are situated within
the large groove of the helix.

The possibility, therefore,

exists that the interactions mentioned above could occur
via these groups and especially the 6-phenyl substituent of
the EB molecule.

The behavior of the CD of the DDMB-DNA

complex is an indication to the contrary.

DDMB is the 5,6-

dimethyl analogue of EB and the CD spectrum of its complex
with DNA is both qualitatively and quantitatively very similar to that of the EB-DNA complex.

This finding is an indi-

cation that, if interactions between phenyl groups of intercalated EB molecules occur to any significant degree, such
interactions do not contribute appreciably to the CD of the
complex near 300 nm.
It appears, therefore, that interactions between
intercalated diamino phenanthridinium molecules are exerted
from one drug molecule to the other mainly via the intervening base pairs.
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2.3.

Differences in the properties of DNA complexes of mono-

and diamino phenanthridinium dyes
2.3.1.

CD evidence
In comparison with the spectra of the complexes of

the diamino phenanthridinium dyes with DNA, the CD spectra
below 350 nm of the monoamino phenanthridinium-DNA complexes
appear distinctly different, both in terms of shape as well
as magnitude.

Although molar ellipticity near 310 nm appears

to depend on r, the observed increase in £ 1 - ~r is much
weaker than that exhibited by the diamino phenanthridinium
complexes.

In addition, and perhaps more significantly,

the shape of the CD spectrum itself changes with increasing
dye/nucleotide ratio.

Considering that changes in CD fre-

quently reflect changes in the conformation of the macromolecule under study, this observation might be considered
as indicative of differences in the conformation of the
drug-DNA complex, depending on whether a mono- or a diamino
phenanthridinium compound is intercalated.
Such differences in the circular dichroism spectra
of the two classes of complexes are not unexpected, if
certain conditions necessary for inducing optical activity
are taken into consideration.

Induction of optical activity

requires that the intercalated molecules be maintained in a
specific orientation with respect to one another (Yamaoka
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and Resnik, 1966).

Molecules, therefore, not properly

oriented within their intercalation sites would not be expected to exhibit strong induced optical activity.
According to the model originally proposed by Fuller
and Waring for the DNA-EB complex, the primary amino groups
at positions 3 and 8 of the EB molecule contribute. to the
overall stabilization of the complex by forming hydrogen
bonds with the phosphate groups on the backbone of the helix.
Conceivably, these hydrogen bonds may also contribute in
maintaining the intercalated molecule in a specific orientation within its binding site.
role for the

c3

and the

c8

The possibility of such a

amino groups was also considered

recently (Wakelin and Waring, 1974) but a direct experimental testing of this possibility was not attempted.

This

orientation seems to be the most favorable for near neighbor
interactions and it may be responsible for the increased·
optical activity observed with complexes formed between DNA
and EB or DDMB.
Furthermore, this particular positioning may be
difficult to maintain when the intercalated molecule lacks
the amino group at the

c3

hydrogen bond between that

position.
gro~p

The absence of the

and a DNA phosphate would

be expected to increase the freedom of movement of the intercalated molecule within its binding site.

Thus, the inter-

calated molecule would not be restricted to the specific

r
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orientation associated with strong optical activity near
310 run, which would result in the significantly reduced
ellipticity in the 300-350 run region observed for the complexes of DNA with MAPAC, MAPEC or MMPB.
2.3.2.

Fluorescence evidence
The existence of differences in the conformation of

the phenanthridinium-DNA complexes is further confirmed by
the considerable increase in the fluorescence of the diamino
compounds upon binding to DNA, whereas, under identical conditions, only a slight increase, if any, is observed with
the monoamino derivatives.
Immersion of the intercalated molecule in the hydrophobic interior of DNA has been implicated as the reason for
the increased fluorescence of intercalated EB molecules
(LePecq and Paoletti, 1967).

The main argument supporting

this conclusion was the observed increase in the quantum
efficiency of EB in nonpolar solvents.

It was reported that,

when EB is dissolved in ethylene glycol, methanol, ethanol,
propanol, butanol or octanol, its quantum efficiency increases from ethylene glycol to ethanol.

The quantum efficien-

cy in ethanol is about six times greater than in water, but
it decreases slightly from ethanol to octanol (LePecq and
Paoletti, 1967).

Similar observations were reported for

various other aromatic hydrocarbons, the fluorescence
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intensity of which increases with decreasing solvent polari-_
ty (Majumdar and Basu, 1960; Van Duuren, 1963; Stryer,
1965).
The differences, therefore, observed in the fluorescence enhancement between the mono- and the diamino phenanthridinium compounds may be an indication that these two
classes of compounds interact to different extents with the
hydrophobic environment of the nucleic acid.
By studying the decay of the emission anisotropy of
the EB-DNA complex, Wahl and his co-workers (Wahl et al.,
1970) obtained evidence that the intercalated drug molecules
are subject to internal Brownian motion.

This motion consists

of an oscillation of the bound molecules within their plane
of intercalation.

The angle of the oscillation was estimated

to approximately 35°.

This angle is probably limited by

the two hydrogen bonds formed between the two amino groups
of the EB molecule and the phosphate groups on the two DNA
strands.

The intercalated molecule is, therefore, only

following the transient local unwinding ("breathing") of the
helix (Wahl et al., 1970).
In contrast, such a topological restriction is
probably not imposed upon the monoamino compounds.
molecules lack the amino group at the

c3

position.

These
Conse-

quently, they can only form one hydrogen bond, namely that
between their 8-amino group and a DNA phosphate group.
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Therefore, the freedom of oscillation of monoamino phenanthridinium compounds within their intercalation plane is
expected to be higher than that of the diamino compounds
and the field of movement of the monoamino derivatives is
not restricted to the hydrophobic volume between successive
base pairs, but may extend into the aqueous environment
surrounding the nucleic acid as well.

Put in another way,

if two types of environment are considered, i.e. a hydrophobic one, between the DNA base pairs, and an aqueous,
surrounding the DNA-drug complex, then the distribution of
the diamino compounds in the hydrophobic medium at any given
moment is expected to be higher than the corresponding
distribution of the monoamino derivatives.
However, as it was mentioned earlier, the polarity
of the environment has a profound effect on the quantum
yield of aromatic compounds.

It has been reported that the

quantum yield of at least one such compound, l-anilino-8napthalene sulfonate (ANS), decreases dramatically with
increasing water content of the solvent (Stryer, 1965).
Therefore, the, even partial, immersion of the monoamino
phenanthridinium dyes into an aqueous environment would be
expected to have a considerable quenching effect on their
fluorescence intensity.

On the other hand, the quantum

efficiency of the intercalated diamino derivatives would be
expected to increase considerably over that of the free dye,
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since these compounds are almost always located within the
less polar environment of the interior of the nucleic acid.
The above model of differential distribution of
mono- and diamino compounds into the hydrophobic environment of the DNA base pairs also provides an explanation for
the modest increase in fluorescence of MMPB upon binding to
DNA.

As indicated in the Results (Section 3), the fluores-

cence of MMPB increases approximately 5-fold upon binding to
DNA, whereas the fluorescence of the other two monoamino
drugs studied, MAPAC and MAPEC, shows no significant changes.
This difference on fluorescence enhancement may be an indication that the exposure of MAPAC and MAPEC to the aqueous
environment of the solution is higher than that of MMPB.
The reason for this may lie in the differences in the substituents at the

c6

position between MMPB and the other two

monoamino phenanthridinium derivatives.

The

c6

substituents,

according to the original intercalation model (Fuller and
Waring, 1964), are situated within the major groove of the
DNA helix and are in contact with the medium surrounding
the polynucleotide.

It is expected, therefore, that the

relatively more polar Q-aminophenyl group at position

c6

of

MAPAC and MAPEC will tend to increase the exposure of the
phenanthridinium ring to the aqueous environment more than
the relatively more hydrophobic 6-phenyl substituent of MMPB.
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3.

THE COMPLEX AS AN ENZYMIC SUBSTRATE
The conformation and stability of the phenanthridi-

nium-DNA complex are expected to affect the ability of this
complex to serve as template or substrate for DNA polymerase
or DNase respectively.

Both DNA polymerase and DNase have

well defined requirements regarding the conformation of the
nucleic acid that serves as their respective template or
substrate (Zimmermann, 1966; Harwood et al., 1970a; Junowicz
and Spencer, 1973; Ehrlich et al., 1973).

Therefore, agents

that affect the DNA conformation will very likely influence
the affinity of these enzymes for the nucleic acid and this
influence will be reflected in the rate of the enzymic
reaction.
3.1.

Modification of the DNA substrate as a result of dye

binding
It has been well established that binding of phenanthridinium compounds alters the topological characteristics
of DNA (Wakelin and Waring, 1974); it has been estimated that
each intercalated molecule unwinds the DNA helix by 8 - 12°
(Pigram et al., 1973; Wakelin and Waring, 1974) and possibly
by as much as 26° (Wang, 1974) .. Even if it is assumed that
the change in the conformation of the DNA induced by dye
binding is not being transmitted more than a few base pairs
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along the helix, the overall conformational change will be
proportional to the number of drug molecules bound to it.
Since the ability of an enzyme to recognize its substrate
and bind effectively to it depends on the conformation of the
substrate, it should be expected that the activity of the
enzyme be inversely related to the concentration of the
bound dye.
A possible alternative to the mechanism of inhibition just described involves the substituents of the phenanthridiniurn molecules at positions 5 and 6 of the ring.
According to the original intercalative model of Fuller and
Waring (1964), these groups are not inserted between the
base pairs but lie in the large groove of the helix.

There-

fore, they probably do not affect directly the DNA conformation (Results, Section 2), but they may reduce the affinity
of the enzyme for its substrate by sterically preventing the
binding of the enzyme to DNA.

Specifically, molecules with

bulky groups at the 5 and/or 6 positions of the ring would be
expected to be more effective inhibitors of the enzyme activity than the derivatives with small alkyl groups at these
positions.
Finally, enzymic inhibition may result from the
stabilization of the double-stranded form of DNA.

It was

shown that the phenanthridiniurn compounds preferentially
stabilize that form (Results, Section 4) and that this stabilization increases with increasing added dye/nucleotide
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ratio (Martz, 1971; Waring, 1974).

Therefore, if the enzyme

requires a single-stranded substrate (or template), this
preferential stabilization of double-helical DNA will result
in decreased enzymic activity.
The three possible mechanisms of inhibition described above appear to participate,

alb~it

to different

extent in each case, to the inhibition of DNase and DNA
polymerase by the phenanthridinium compounds.
3.2.

Inhibition of DNase
The first two mechanisms, namely those involving

conformational change of the substrate and physical prevention of binding, appear to play a major role in the inhibition of DNase.

On the contrary, stabilization of the DNA

double-helix is not expected to be a significant factor in
the inhibition of this enzyme, since DNase I is, in fact,
known to hydrolyze native DNA faster than denatured DNA
(Dirksen and Dekker, 1958).
The effect of the dye-DNA complex conformation on
the activity of DNase is indicated by the linear dependence
of the inhibition of this enzyme on the.bound dye/nucleotide
ratio, as suggested by the inhibition mechanism (Discussion,
Section 3.1).

In addition, the different rates of DNase

inhibition observed with different phenanthridinium derivatives indicate that the groups at positions 5 and/or 6 of
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the ring contribute to the inhibition of DNase by these
compounds.

Indeed, as judged from the slopes in the linear

portion of the dependence of enzyme inhibition on £, it
appears that drugs with a 6-phenyl substituent are somewhat
stronger inhibitors than the 5,6-dimethyl derivative.
3.3.

Inhibition of DNA polymerase
In contrast, in the case of DNA polymerase, the

above two factors affecting inhibition, i.e. conformational
change of the template and physical prevention of binding,
are not expected to affect significantly the activity of the
enzyme, at least as far as its initial binding to the template
is concerned, under the experimental conditions used.

This

is because the template used for the assay was "activated",
i.e. the DNA was pretreated briefly with DNase so that
single-stranded nicks were introduced to it.

It has been·

shown (Kornberg, 1969) that DNA polymerase binds preferentially and quantitatively to single stranded nicks of the
template.

However, it is in the immediate vicinity of the

nicks that the double-helical structure of the DNA is the
less stable.

Since EB is known to bind preferentially to

the double-stranded structure, the density of the intercalated molecules population close to the nicks would be significantly lower than the average density for the remaining
DNA molecule.

It follows, therefore, that, since nicks

l~

constitute major polymerase binding sites, the intercalation of phenanthridinium compounds to DNA will not affect
significantly the binding of the polymerase to its template.
Although the initial binding of the polymerase to
its template may not be substantially inhibited by the
intercalated phenanthridinium dyes, the propagation of the
enzyme along the DNA molecule could be hindered by the presence of these compounds.

Undoubtedly, a major part of this

inhibition of propagation is due to the stabilization of the
double-helical form of the DNA by the intercalated dye.

The

physical separation of the two parent strands during DNA
replication was established with the classical experiments
of Meselson and Stahl (Meselson and Stahl, 1958), as well as
with subsequent studies with similar aims (Cairns, 1962;
Baldwin and Shooter, 1963).

Agents, therefore, inhibiting

this strand separation would effectively inhibit replication
of DNA.
Since phenanthridinium dyes preferentially stabilize
the helical form of DNA, as evidenced by the increased Tm
values of the dye-DNA complexes (Results, Section 4), it is
not surprising that replication of DNA is substantially inhibited in the presence of these compounds.

Evidence suppor-

ting such a relationship between stabilization of the DNA
double-helix and inhibition of DNA polymerase is provided
by the similarity of the dependence of these two properties
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on the added dye/nucleotide ratio.

Indeed, the dependence

of inhibition of DNA polymerase versus added EB/DNA ratio
(Figure 62) is very similar to that of the Tm of calf thymus
DNA versus the same ratio (Waring, 1974).

Furthermore, the

same similarity is observed for another intercalative compound, acridine orange, which also increases the melting
temperature of DNA (Kleinwachter and Koudelka, 1964) and
inhibits the activity of DNA polymerase (Eberhard and Herrmann, 1972).
In addition, it appears that the size of the substi tuent at position 6 of the phenanthridinium ring may also
play a role in determining the extent of polymerase inhibition by the phenanthridinium derivatives.

Indeed, small

differences are observed in the inhibitory effect of these
compounds on the activity of DNA polymerase; these differences suggest that 6-phenyl-substituted drugs are slightly
more effective inhibitors than the derivative with a relatively small ethyl group at position 6.

Since no difference

in the stabilization of DNA was observed between those compounds, the slightly stronger inhibitory effect of the
6-phenyl derivatives may be related to the presence of the
bulky phenyl substituent, which projects into the major groove
of DNA and which may impede further the propagation of the
enzyme along the template.
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3.4.

Some biological implications of the inhibition of DNA

polymerase
As early as 1957, it was observed that DNA synthesis
in certain organisms is drastically inhibited in the presence
of EB (Newton, 1957).

In addition, inhibition of mitochon-

drial DNA synthesis by EB has been reported in a variety of
organisms (Riou, 1967b; Goldring et al., 1970; Radsak et al.,
1971).

In many cases, inhibition of DNA synthesis is accom-

panied by alterations in the morphology and physiology of
the organism under study (Riou, 1967a; Nass, 1970; Heilporn
and Limbosch, 1971; Goldring et al., 1971).

It is likely,

therefore, that inhibition of DNA polymerase may be a major
factor influencing the biological activity of the phenanthridinium compounds on the molecular level. · However, the
role of DNA polymerase I in DNA replication has not been
unequivocally established.

It has been suggested (Okazaki

et al., 1971) that this enzyme serves to close the gaps in
the daughter strand of the DNA which result from the discontinuous DNA synthesis (Okazaki et al., 1968).

Also, it

is believed that DNA polymerase I participates in the repair
of UV-induced damage to the nucleic acid (Harwood and Wells,
1970; Hamilton et al., 1974).
Evidence compatible with both of these hypotheses
was obtained recently.

The mitochondrial DNA of HeLa cells

grown in the presence of EB is fragmented into pieces which
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are approximately one-tenth the size of the original DNA
molecule (Koch, 1973).

Since, unlike nuclear DNA, the mito-

chondrial DNA of mammalian cells is continuously degraded
and replaced by newly synthesized mitDNA (Gross et al.,
1969; Koch, 1972), two interpretations were advanced to
account for this fragmentation of mitDNA in the presence of
EB.

It may be assumed that the mitDNA is normally subject

to single stranded nicks which are subsequently closed by a
DNA polymerase I-like enzyme,

According to this mechanism,

EB inhibition of this enzyme results in the accumulation of
mitDNA fragments.

Alternatively, it may be assumed that

nicking constitutes part of the normal degradation process
for mitochondrial DNA; EB then is believed to act by inhibiting a DNA polymerase that is reponsible for the de

!!QYQ.

synthesis of mitDNA (Koch, 1973).
Furthermore, EB was found to

inhi~it

the host cell

mediated reactivation of UV-irradiated bacteriophage Tl as
well as to enhance UV-induced mutation rate and lethality
in h

coli possessing the dark repair mechanism (Shankel a·nd

Molholt, 1973).

Host cell reactivating ability and resis-

tance to UV radiation were repeatedly associated with the
presence of active DNA polymerase I (DeLucia and Cairns,
1969; Kato and Koudo, 1970; McPhee, 1974) indicating that one
of the biological functions of this enzyme is the repair of
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UV-induced DNA damage.

It is conceivable, therefore, that

the observed increase in UV sensitivity of

~

coli and

bacteriophage Tl in the presence of EB is due to inhibition
by the dye of the activity of DNA polymerase I.

SUMMARY
Ethidium bromide (EB) and some of its analogs are
known to bind to DNA by intercalation and preferentially
stabilize its double-stranded form, as indicated by the
increased Tm values noted for the resulting complexes.
Hydrophobic forces between the phenanthridinium rind and
the DNA bases are major contributors to the binding.

Bind-

ing parameters for the 3,8-diamino derivatives are slightly
higher than those for the 3-monoamino compounds, indicating
that hydrogen bonds between the 3- and 8-amino groups and
the DNA phosphate residues confer additional stabilization
to the complex.

This conclusion is further reinforced by

the observed decrease in binding parameters at high ionic
strength.
Examination of the CD spectra of the phenanthridinium-DNA complexes reveals several bands in the 300 - 600 run
region.

Molar ellipticities in the long (470 - 500 run)

band are independent of complex concentration; therefore,
optical activity in this region may be ascribed to the influence of the asymmetric environment of the binding site
on the intercalated molecule.
The molar ellipticity near 310 run increases with
increasing bound dye/nucleotide ratio (r), indicating that
167
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optical activity at this wavelength depends on the "population density" of bound molecules.

Since the CD of the

EB-DNA complex near 310 nm exhibits, at least at high ionic
strength, an exciton doublet, the optical activity of the
diamino phenanthridinium-DNA complexes at this wavelength
may be attributed to direct interactions between dye molecules intercalated at neighboring sites.
In the case of the monoamino dye-DNA complexes, a
significant and gradual modification of the overall shape
of the CD spectrum takes place with increasing r.

The

distinctly different behavior of the CD of the monoamino
dye-DNA complexes suggests a different orientation of these
compounds within their binding sites.

This may result from

the inability of the monoamino derivatives to form a second
hydrogen bond with DNA residues.
Differences in the positioning of the intercalated
molecules are also indicated by the differences in the
enhancement of the fluorescence intensity of the mono- and
diamino derivatives upon binding to DNA.

The fluorescence

intensity of the diamino derivatives increases 20- to 30-fold
upon complexing with DNA, whereas a small, if any, increase
is observed with the monoamino compounds.

The increase in

fluorescence intensity of the dye is attributed to the
influence of the hydrophobic environment of the interior of
the DNA on the intercalated molecule.

The much smaller

increase in fluorescence of the monoamino dyes indicates

169

that the exposure of these compounds to the aqueous medium
is more pronounced than that of the diamino derivatives.
This assumption is consistent with the inability of the
monoamino dyes to form a second hydrogen bond with DNA
phosphate residues.
Differences in the conformation of the complexes
of DNA with the phenanthridinium dyes are also consistent
with the pattern of inhibition of DNase I and DNA polymerase
I by these compounds.

The finding that, in both cases, the

inhibition if overcome by increased DNA concentration,
suggests that inhibition results from the binding of the
drugs to DNA rather than from direct drug-enzyme interactions.
The inhibition of DNase by the phenanthridinium dyes is
probably due to an alteration in the conformation of the
substrate leading to a decrease in the affinity of the enzyme for it.

In contrast, a stabilization of the double- ·

stranded form of the template may be an important factor in
the inhibition of DNA polymerase, since strand separation
is a prerequisite for the action of this enzyme.
For both enzymes, 6-phenyl compounds are slightly
more effective inhibitors than the 6-methyl or 6-ethyl
substituted derivatives.

It appears that a bulky group at

position 6 of the phenanthridinium ring increases the effectiveness of the inhibitor by sterically preventing the
binding and/or the propagation of the enzyme on the substrate
or the template.
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